Document:

Exhibit 4.1

 

THIS WARRANT AND THE UNDERLYING SECURITIES
HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), OR UNDER THE SECURITIES LAWS
OF ANY STATE. THESE SECURITIES MAY NOT BE OFFERED, SOLD OR OTHERWISE TRANSFERRED, PLEDGED OR HYPOTHECATED EXCEPT AS PERMITTED UNDER
THE ACT AND APPLICABLE STATE SECURITIES LAWS IN ACCORDANCE WITH APPLICABLE REGISTRATION REQUIREMENTS OR AN EXEMPTION THEREFROM.
THE ISSUER OF THESE SECURITIES MAY REQUIRE AN OPINION OF COUNSEL REASONABLY SATISFACTORY TO THE ISSUER THAT SUCH OFFER, SALE, TRANSFER,
PLEDGE OR HYPOTHECATION OTHERWISE COMPLIES WITH THE ACT AND ANY APPLICABLE STATE SECURITIES LAWS.

 

WITHOUT COMPLIANCE WITH ALL APPLICABLE
SECURITIES LEGISLATION, NEITHER THIS WARRANT NOR THE WARRANT SHARES MAY BE SOLD, TRANSFERRED, HYPOTHECATED OR OTHERWISE TRADED
IN CANADA OR TO OR FOR THE BENEFIT OF A CANADIAN RESIDENT UNTIL FOUR MONTHS FROM THE ORIGINAL ISSUE DATE SET FORTH BELOW.

 

COMMON STOCK PURCHASE WARRANT

 

CohBar,
Inc.

 

	Warrant Shares: _______	Original Issue Date: [●], 2020
	 	Initial Exercise Date: [●], 2021

  

THIS COMMON STOCK PURCHASE
WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”)
is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on
or after [●], 2021 (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on
[●], 2026 (the “Termination Date”) but not thereafter, to subscribe for and purchase from CohBar, Inc.,
a Delaware corporation (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant
Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise
Price, as defined in Section 2(b).

 

Section 1. Definitions.
In addition to the terms defined elsewhere in this Warrant, the following terms have the meanings indicated in this Section 1:

 

“Affiliate”
means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common
control with a Person, as such terms are used in and construed under Rule 405 under the Securities Act.

 

    1

     

    

 

“Bid
Price” means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common
Stock is then listed or quoted on a Trading Market, the bid price of the Common Stock for the time in question (or the nearest
preceding date) on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg L.P. (based on
a Trading Day from 9:30 a.m. (New York City time) to 4:02 p.m. (New York City time)), (b)  if OTCQB or OTCQX is not a Trading
Market, the volume weighted average price of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as
applicable, (c) if the Common Stock is not then listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock
are then reported on the Pink Open Market (or a similar organization or agency succeeding to its functions of reporting prices),
the most recent bid price per share of the Common Stock so reported, or (d) in all other cases, the fair market value of a
share of Common Stock as determined by an independent appraiser selected in good faith by the Holders of a majority in interest
of the Warrants then outstanding and reasonably acceptable to the Company, the fees and expenses of which shall be paid by the
Company.

 

“Board
of Directors” means the board of directors of the Company.

 

“Business
Day” means any day other than Saturday, Sunday or other day on which commercial banks in The City of New York are authorized
or required by law to remain closed; provided, however, for clarification, commercial banks shall not be deemed to
be authorized or required by law to remain closed due to “stay at home”, “shelter-in-place”, “non-essential
employee”  or any other similar orders or restrictions or the closure of any physical branch locations at the direction
of any governmental authority so long as the electronic funds transfer systems (including for wire transfers) of commercial banks
in The City of New York generally are open for use by customers on such day.

 

“Commission”
means the United States Securities and Exchange Commission.

 

“Common
Stock” means the common stock of the Company, par value $0.001 per share, and any other class of securities into which
such securities may hereafter be reclassified or changed.

 

“Common
Stock Equivalents” means any securities of the Company or the Subsidiaries which would entitle the holder thereof to
acquire at any time Common Stock, including, without limitation, any debt, preferred stock, right, option, warrant or other instrument
that is at any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive, Common
Stock.

 

“Exchange
Act” means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.

 

“Person”
means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability
company, joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.

 

“Securities
Act” means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.

 

    2

     

    

 

“Subsidiary”
means any subsidiary of the Company and shall, where applicable, also include any direct or indirect subsidiary of the Company
formed or acquired after the date hereof.

 

“Trading
Day” means a day on which the Common Stock is traded on a Trading Market.

 

“Trading
Market” means any of the following markets or exchanges on which the Common Stock is listed or quoted for trading on
the date in question: the NYSE American, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market,
the New York Stock Exchange, OTCQB or OTCQX (or any successors to any of the foregoing).

 

“Transfer
Agent” means AST Trust Company (Canada), the current transfer agent of the Company, with a mailing address of 1066 West
Hastings Street, Suite 1600, Vancouver, BC V6E 3X1 and a facsimile number of 604-235-3705 and an email address of tmurphy@astfinancial.com,
and any successor transfer agent of the Company.

 

“VWAP”
means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed
or quoted on a Trading Market, the daily volume weighted average price of the Common Stock for such date (or the nearest preceding
date) on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg L.P. (based on a Trading
Day from 9:30 a.m. (New York City time) to 4:02 p.m. (New York City time)), (b)  if OTCQB or OTCQX is not a Trading Market,
the volume weighted average price of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable,
(c) if the Common Stock is not then listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then
reported on the Pink Open Market (or a similar organization or agency succeeding to its functions of reporting prices), the most
recent bid price per share of the Common Stock so reported, or (d) in all other cases, the fair market value of a share of
Common Stock as determined by an independent appraiser selected in good faith by the holders of a majority in interest of the Warrants
then outstanding and reasonably acceptable to the Company, the fees and expenses of which shall be paid by the Company.

 

“Warrants”
means this Warrant and other Common Stock purchase warrants issued by the Company in the offering in which this Warrant was issued.

  

    3

     

    

 

Section 2. Exercise.

 

a) Exercise
of Warrant. Exercise of the purchase rights represented by this Warrant may be made, in whole or in part, at any time or times
on or after the Initial Exercise Date and on or before the Termination Date by delivery to the Company (with a facsimile copy or
PDF copy to the Transfer Agent delivered via facsimile at the facsimile number or via e-mail at the e-mail address set forth in
the definition of Transfer Agent above (or such other office or agency as the Company may designate by notice in writing to the
registered Holder at the address of the Holder appearing on the books of the Company)) of a duly executed facsimile copy or PDF
copy submitted by e-mail (or e-mail attachment) of the Notice of Exercise in the form annexed hereto (the “Notice of Exercise”).
Within the earlier of (i) two (2) Trading Days and (ii) the number of Trading Days comprising the Standard Settlement Period (as
defined in Section 2(d)(i) herein) following the date of exercise as aforesaid, the Holder shall deliver the aggregate Exercise
Price for the shares specified in the applicable Notice of Exercise by wire transfer or cashier’s check drawn on a United
States bank unless the cashless exercise procedure specified in Section 2(c) below is specified in the applicable Notice of Exercise.
No ink-original Notice of Exercise shall be required, nor shall any medallion guarantee (or other type of guarantee or notarization)
of any Notice of Exercise be required. Notwithstanding anything herein to the contrary, the Holder shall not be required to physically
surrender this Warrant to the Company until the Holder has purchased all of the Warrant Shares available hereunder and the Warrant
has been exercised in full, in which case, the Holder shall surrender this Warrant to the Company for cancellation within three
(3) Trading Days of the date on which the final Notice of Exercise is delivered to the Company. Partial exercises of this Warrant
resulting in purchases of a portion of the total number of Warrant Shares available hereunder shall have the effect of lowering
the outstanding number of Warrant Shares purchasable hereunder in an amount equal to the applicable number of Warrant Shares purchased.
The Holder and the Company shall maintain records showing the number of Warrant Shares purchased and the date of such purchases.
The Company shall deliver any objection to any Notice of Exercise within one (1) Business Day of receipt of such notice. The
Holder and any assignee, by acceptance of this Warrant, acknowledge and agree that, by reason of the provisions of this paragraph,
following the purchase of a portion of the Warrant Shares hereunder, the number of Warrant Shares available for purchase hereunder
at any given time may be less than the amount stated on the face hereof.

 

b) Exercise
Price. The exercise price per share of Common Stock under this Warrant shall be $1.44, subject to adjustment hereunder
(the “Exercise Price”).

 

c) Cashless
Exercise. If at the time of exercise hereof there is no effective registration statement registering, or the prospectus contained
therein is not available for the issuance of the Warrant Shares to the Holder, then this Warrant may also be exercised, in whole
or in part, at such time by means of a “cashless exercise” in which the Holder shall be entitled to receive a number
of Warrant Shares equal to the quotient obtained by dividing [(A-B) (X)] by (A), where:

 

    4

     

    

 

	 	(A)   	=	as applicable: (i) the VWAP on the Trading Day immediately preceding the date of the applicable Notice of Exercise if such Notice of Exercise is (1) both executed and delivered pursuant to Section 2(a) hereof on a day that is not a Trading Day or (2) both executed and delivered pursuant to Section 2(a) hereof on a Trading Day prior to the opening of “regular trading hours” (as defined in Rule 600(b)(68) of Regulation NMS promulgated under the federal securities laws) on such Trading Day, (ii) at the option of the Holder, either (y) the VWAP on the Trading Day immediately preceding the date of the applicable Notice of Exercise or (z) the Bid Price of the Common Stock on the principal Trading Market as reported by Bloomberg L.P. as of the time of the Holder’s execution of the applicable Notice of Exercise if such Notice of Exercise is executed during “regular trading hours” on a Trading Day and is delivered within two (2) hours thereafter (including until two (2) hours after the close of “regular trading hours” on a Trading Day) pursuant to Section 2(a) hereof or (iii) the VWAP on the date of the applicable Notice of Exercise if the date of such Notice of Exercise is a Trading Day and such Notice of Exercise is both executed and delivered pursuant to Section 2(a) hereof after the close of “regular trading hours” on such Trading Day;
	 	 	 	 
	 	(B)	=	the Exercise Price of this Warrant, as adjusted hereunder; and
	 	 	 	 
	 	(X)	=	the number of Warrant Shares that would be issuable upon exercise of this Warrant in accordance with the terms of this Warrant if such exercise were by means of a cash exercise rather than a cashless exercise.

 

If Warrant
Shares are issued in such a cashless exercise, the parties acknowledge and agree that in accordance with Section 3(a)(9) of the
Securities Act, the Warrant Shares shall take on the characteristics of the Warrants being exercised, and the holding period of
the Warrant Shares being issued may be tacked on to the holding period of this Warrant. The Company agrees not to take any position
contrary to this Section 2(c).

 

Notwithstanding
anything herein to the contrary, on the Termination Date, this Warrant shall be automatically exercised via cashless exercise pursuant
to this Section 2(c).

 

    5

     

    

 

		d)	Mechanics of Exercise.

 

		i.	Delivery of Warrant Shares Upon Exercise. The Company shall cause the Warrant Shares purchased
hereunder to be transmitted by the Transfer Agent to the Holder by crediting the account of the Holder’s or its designee’s
balance account with The Depository Trust Company through its Deposit or Withdrawal at Custodian system (“DWAC”)
if the Company is then a participant in such system and either (A) there is an effective registration statement permitting the
issuance of the Warrant Shares to or resale of the Warrant Shares by Holder or (B) the Warrant Shares are eligible for resale by
Holder without volume or manner-of-sale limitations pursuant to Rule 144 promulgated under the Securities Act and this Warrant
is being exercised via cashless exercise, and otherwise by physical delivery of a certificate, registered in the Company’s
share register in the name of the Holder or its designee, for the number of Warrant Shares to which the Holder is entitled pursuant
to such exercise to the address specified by the Holder in the Notice of Exercise by the date that is the earliest of (i) two (2)
Trading Days after the delivery to the Company of the Notice of Exercise, (ii) one (1) Trading Day after delivery of the aggregate
Exercise Price to the Company and (iii) the number of Trading Days comprising the Standard Settlement Period after the delivery
to the Company of the Notice of Exercise, and, in the case of each of (i) and (iii), subject to the Company’s receipt of
the aggregate Exercise Price (such date, the “Warrant Share Delivery Date”). Upon delivery of the Notice of
Exercise, the Holder shall be deemed for all corporate purposes to have become the holder of record of the Warrant Shares with
respect to which this Warrant has been exercised, irrespective of the date of delivery of the Warrant Shares, provided that payment
of the aggregate Exercise Price (other than in the case of a cashless exercise) is received within the earlier of (i) two (2) Trading
Days and (ii) the number of Trading Days comprising the Standard Settlement Period following delivery of the Notice of Exercise.
If the Company fails for any reason to deliver to the Holder the Warrant Shares subject to a Notice of Exercise by the Warrant
Share Delivery Date, the Company shall pay to the Holder, in cash, as liquidated damages and not as a penalty, for each $1,000
of Warrant Shares subject to such exercise (based on the VWAP of the Common Stock on the date of the applicable Notice of Exercise),
$10 per Trading Day (increasing to $20 per Trading Day on the fifth Trading Day after such liquidated damages begin to accrue)
for each Trading Day after such Warrant Share Delivery Date until such Warrant Shares are delivered or Holder rescinds such exercise.
The Company agrees to maintain a transfer agent that is a participant in the FAST program so long as this Warrant remains outstanding
and exercisable. As used herein, “Standard Settlement Period” means the standard settlement period, expressed
in a number of Trading Days, on the Company’s primary Trading Market with respect to the Common Stock as in effect on the
date of delivery of the Notice of Exercise.

 

ii. Delivery
of New Warrants Upon Exercise. If this Warrant shall have been exercised in part, the Company shall, at the request of a Holder
and upon surrender of this Warrant certificate, at the time of delivery of the Warrant Shares, deliver to the Holder a new Warrant
evidencing the rights of the Holder to purchase the unpurchased Warrant Shares called for by this Warrant, which new Warrant shall
in all other respects be identical with this Warrant.

 

iii. Rescission
Rights. If the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares pursuant to Section 2(d)(i)
by the Warrant Share Delivery Date, then the Holder will have the right to rescind such exercise, and the Company shall return
all consideration paid by the Holder for such shares upon such rescission. Notwithstanding anything herein to the contrary, the
Company shall not be required to make any cash payments to the Holder in lieu of issuance of the Warrant Shares.

 

    6

     

    

 

iv. Compensation
for Buy-In on Failure to Timely Deliver Warrant Shares Upon Exercise. In addition to any other rights available to the Holder,
if the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares in accordance with the provisions
of Section 2(d)(i) above pursuant to an exercise on or before the Warrant Share Delivery Date, and if after such date the Holder
is required by its broker to purchase (in an open market transaction or otherwise) or the Holder’s brokerage firm otherwise
purchases, shares of Common Stock to deliver in satisfaction of a sale by the Holder of the Warrant Shares which the Holder anticipated
receiving upon such exercise (a “Buy-In”), then the Company shall (A) pay in cash to the Holder the amount,
if any, by which (x) the Holder’s total purchase price (including brokerage commissions, if any) for the shares of Common
Stock so purchased exceeds (y) the amount obtained by multiplying (1) the number of Warrant Shares that the Company was required
to deliver to the Holder in connection with the exercise at issue times (2) the price at which the sell order giving rise to such
purchase obligation was executed, and (B) at the option of the Holder, either reinstate the portion of the Warrant and equivalent
number of Warrant Shares for which such exercise was not honored (in which case such exercise shall be deemed rescinded) or deliver
to the Holder the number of shares of Common Stock that would have been issued had the Company timely complied with its exercise
and delivery obligations hereunder. For example, if the Holder purchases Common Stock having a total purchase price of $11,000
to cover a Buy-In with respect to an attempted exercise of shares of Common Stock with an aggregate sale price giving rise to such
purchase obligation of $10,000, under clause (A) of the immediately preceding sentence the Company shall be required to pay the
Holder $1,000. The Holder shall provide the Company written notice indicating the amounts payable to the Holder in respect of the
Buy-In and, upon request of the Company, evidence of the amount of such loss. Nothing herein shall limit a Holder’s right
to pursue any other remedies available to it hereunder, at law or in equity including, without limitation, a decree of specific
performance and/or injunctive relief with respect to the Company’s failure to timely deliver shares of Common Stock upon
exercise of the Warrant as required pursuant to the terms hereof.

 

v. No
Fractional Shares or Scrip. No fractional shares or scrip representing fractional shares shall be issued upon the exercise
of this Warrant. As to any fraction of a share which the Holder would otherwise be entitled to purchase upon such exercise, the
Company shall, at its election, either pay a cash adjustment in respect of such final fraction in an amount equal to such fraction
multiplied by the Exercise Price or round up to the next whole share.

 

vi. Charges,
Taxes and Expenses. Issuance of Warrant Shares shall be made without charge to the Holder for any issue or transfer tax or
other incidental expense in respect of the issuance of such Warrant Shares, all of which taxes and expenses shall be paid by the
Company, and such Warrant Shares shall be issued in the name of the Holder or in such name or names as may be directed by the Holder;
provided, however, that, in the event that Warrant Shares are to be issued in a name other than the name of the Holder,
this Warrant when surrendered for exercise shall be accompanied by the Assignment Form attached hereto duly executed by the Holder
and the Company may require, as a condition thereto, the payment of a sum sufficient to reimburse it for any transfer tax incidental
thereto. The Company shall pay all Transfer Agent fees required for same-day processing of any Notice of Exercise and all fees
to the Depository Trust Company (or another established clearing corporation performing similar functions) required for same-day
electronic delivery of the Warrant Shares.

 

    7

     

    

 

vii. Closing
of Books. The Company will not close its stockholder books or records in any manner which prevents the timely exercise of this
Warrant, pursuant to the terms hereof.

 

e) Holder’s
Exercise Limitations. The Company shall not effect any exercise of this Warrant, and a Holder shall not have the right to exercise
any portion of this Warrant, pursuant to Section 2 or otherwise, to the extent that after giving effect to such issuance after
exercise as set forth on the applicable Notice of Exercise, the Holder (together with the Holder’s Affiliates, and any other
Persons acting as a group together with the Holder or any of the Holder’s Affiliates (such Persons, “Attribution
Parties”)), would beneficially own in excess of the Beneficial Ownership Limitation (as defined below).  For purposes
of the foregoing sentence, the number of shares of Common Stock beneficially owned by the Holder and its Affiliates and Attribution
Parties shall include the number of shares of Common Stock issuable upon exercise of this Warrant with respect to which such determination
is being made, but shall exclude the number of shares of Common Stock which would be issuable upon (i) exercise of the remaining,
nonexercised portion of this Warrant beneficially owned by the Holder or any of its Affiliates or Attribution Parties and (ii)
exercise or conversion of the unexercised or nonconverted portion of any other securities of the Company (including, without limitation,
any other Common Stock Equivalents) subject to a limitation on conversion or exercise analogous to the limitation contained herein
beneficially owned by the Holder or any of its Affiliates or Attribution Parties.  Except as set forth in the preceding sentence,
for purposes of this Section 2(e), beneficial ownership shall be calculated in accordance with Section 13(d) of the Exchange Act
and the rules and regulations promulgated thereunder, it being acknowledged by the Holder that the Company is not representing
to the Holder that such calculation is in compliance with Section 13(d) of the Exchange Act and the Holder is solely responsible
for any schedules required to be filed in accordance therewith. To the extent that the limitation contained in this Section 2(e)
applies, the determination of whether this Warrant is exercisable (in relation to other securities owned by the Holder together
with any Affiliates and Attribution Parties) and of which portion of this Warrant is exercisable shall be in the sole discretion
of the Holder, and the submission of a Notice of Exercise shall be deemed to be the Holder’s determination of whether this
Warrant is exercisable (in relation to other securities owned by the Holder together with any Affiliates and Attribution Parties)
and of which portion of this Warrant is exercisable, in each case subject to the Beneficial Ownership Limitation. To ensure compliance
with this restriction, each Holder will be deemed to represent to the Company each time it delivers a Notice of Exercise that such
Notice of Exercise has not violated the restrictions set forth in this paragraph, and the Company shall have no obligation to verify
or confirm the accuracy of such determination, provided that in making such representation, the Holder is relying on the number
of outstanding shares of Common Stock as reflected in (A) the Company’s most recent periodic or annual report filed with
the Commission, as the case may be, (B) a more recent public announcement by the Company or (C) a more recent written notice by
the Company or the Transfer Agent setting forth the number of shares of Common Stock outstanding. In addition, a determination
as to any group status as contemplated above shall be determined in accordance with Section 13(d) of the Exchange Act and the rules
and regulations promulgated thereunder. For purposes of this Section 2(e), in determining the number of outstanding shares of Common
Stock, a Holder may rely on the number of outstanding shares of Common Stock as reflected in (A) the Company’s most recent
periodic or annual report filed with the Commission, as the case may be, (B) a more recent public announcement by the Company or
(C) a more recent written notice by the Company or the Transfer Agent setting forth the number of shares of Common Stock outstanding. 
Upon the written or oral request of a Holder, the Company shall within two (2) Trading Days confirm orally and in writing to the
Holder the number of shares of Common Stock then outstanding.  In any case, the number of outstanding shares of Common Stock
shall be determined after giving effect to the conversion or exercise of securities of the Company, including this Warrant, by
the Holder or its Affiliates or Attribution Parties since the date as of which such number of outstanding shares of Common Stock
was reported. The “Beneficial Ownership Limitation” shall be 19.99%. The provisions of this paragraph shall
be construed and implemented in a manner otherwise than in strict conformity with the terms of this Section 2(e) to correct this
paragraph (or any portion hereof) which may be defective or inconsistent with the intended Beneficial Ownership Limitation herein
contained or to make changes or supplements necessary or desirable to properly give effect to such limitation. The limitations
contained in this paragraph shall apply to a successor holder of this Warrant.

 

    8

     

    

  

Section 3. Certain
Adjustments.

 

a) Stock
Dividends and Splits. If the Company, at any time while this Warrant is outstanding: (i) pays a stock dividend or otherwise
makes a distribution or distributions on shares of its Common Stock or any other equity or equity equivalent securities payable
in shares of Common Stock (which, for avoidance of doubt, shall not include any shares of Common Stock issued by the Company upon
exercise of this Warrant), (ii) subdivides outstanding shares of Common Stock into a larger number of shares, (iii) combines (including
by way of reverse stock split) outstanding shares of Common Stock into a smaller number of shares, or (iv) issues by reclassification
of shares of the Common Stock any shares of capital stock of the Company, then in each case the Exercise Price shall be multiplied
by a fraction of which the numerator shall be the number of shares of Common Stock (excluding treasury shares, if any) outstanding
immediately before such event and of which the denominator shall be the number of shares of Common Stock outstanding immediately
after such event, and the number of shares issuable upon exercise of this Warrant shall be proportionately adjusted such that the
aggregate Exercise Price of this Warrant shall remain unchanged. Any adjustment made pursuant to this Section 3(a) shall become
effective immediately after the record date for the determination of stockholders entitled to receive such dividend or distribution
and shall become effective immediately after the effective date in the case of a subdivision, combination or re-classification.

 

b) Subsequent
Rights Offerings. In addition to any adjustments pursuant to Section 3(a) above, if at any time the Company grants, issues
or sells any Common Stock Equivalents or rights to purchase stock, warrants, securities or other property pro rata to the record
holders of any class of shares of Common Stock (the “Purchase Rights”), then the Holder will be entitled to
acquire, upon the terms applicable to such Purchase Rights, the aggregate Purchase Rights which the Holder could have acquired
if the Holder had held the number of shares of Common Stock acquirable upon complete exercise of this Warrant (without regard
to any limitations on exercise hereof, including without limitation, the Beneficial Ownership Limitation) immediately before the
date on which a record is taken for the grant, issuance or sale of such Purchase Rights, or, if no such record is taken, the date
as of which the record holders of shares of Common Stock are to be determined for the grant, issue or sale of such Purchase Rights
(provided, however, that, to the extent that the Holder’s right to participate in any such Purchase Right would result in
the Holder exceeding the Beneficial Ownership Limitation, then the Holder shall not be entitled to participate in such Purchase
Right to such extent (or beneficial ownership of such shares of Common Stock as a result of such Purchase Right to such extent)
and such Purchase Right to such extent shall be held in abeyance for the Holder until such time, if ever, as its right thereto
would not result in the Holder exceeding the Beneficial Ownership Limitation).

 

c) Pro
Rata Distributions. During such time as this Warrant is outstanding, if the Company shall declare or make any dividend or other
distribution of its assets (or rights to acquire its assets) to holders of shares of Common Stock, by way of return of capital
or otherwise (including, without limitation, any distribution of cash, stock or other securities, property or options by way of
a dividend, spin off, reclassification, corporate rearrangement, scheme of arrangement or other similar transaction) (a “Distribution”),
at any time after the issuance of this Warrant, then, in each such case, the Holder shall be entitled to participate in such Distribution
to the same extent that the Holder would have participated therein if the Holder had held the number of shares of Common Stock
acquirable upon complete exercise of this Warrant (without regard to any limitations on exercise hereof, including without limitation,
the Beneficial Ownership Limitation) immediately before the date of which a record is taken for such Distribution, or, if no such
record is taken, the date as of which the record holders of shares of Common Stock are to be determined for the participation in
such Distribution (provided, however, that, to the extent that the Holder's right to participate in any such Distribution
would result in the Holder exceeding the Beneficial Ownership Limitation, then the Holder shall not be entitled to participate
in such Distribution to such extent (or in the beneficial ownership of any shares of Common Stock as a result of such Distribution
to such extent) and the portion of such Distribution shall be held in abeyance for the benefit of the Holder until such time, if
ever, as its right thereto would not result in the Holder exceeding the Beneficial Ownership Limitation).

 

    9

     

    

 

d) Fundamental
Transaction. If, at any time while this Warrant is outstanding, (i) the Company, directly or indirectly, in one or more related
transactions effects any merger or consolidation of the Company with or into another Person, (ii) the Company or any Subsidiary,
directly or indirectly, effects any sale, lease, license, assignment, transfer, conveyance or other disposition of all or substantially
all of its assets in one or a series of related transactions, (iii) any, direct or indirect, purchase offer, tender offer or exchange
offer (whether by the Company or another Person) is completed pursuant to which holders of Common Stock are permitted to sell,
tender or exchange their shares for other securities, cash or property and has been accepted by the holders of 50% or more of
the outstanding Common Stock, (iv) the Company, directly or indirectly, in one or more related transactions effects any reclassification,
reorganization or recapitalization of the Common Stock or any compulsory share exchange pursuant to which the Common Stock is
effectively converted into or exchanged for other securities, cash or property, or (v) the Company, directly or indirectly, in
one or more related transactions consummates a stock or share purchase agreement or other business combination (including, without
limitation, a reorganization, recapitalization, spin-off, merger or scheme of arrangement) with another Person or group of Persons
whereby such other Person or group acquires more than 50% of the outstanding shares of Common Stock (not including any shares
of Common Stock held by the other Person or other Persons making or party to, or associated or affiliated with the other Persons
making or party to, such stock or share purchase agreement or other business combination) (each a “Fundamental Transaction”),
then, upon any subsequent exercise of this Warrant, the Holder shall have the right to receive, for each Warrant Share that would
have been issuable upon such exercise immediately prior to the occurrence of such Fundamental Transaction, at the option of the
Holder (without regard to any limitation in Section 2(e) on the exercise of this Warrant), the number of shares of Common Stock
of the successor or acquiring corporation or of the Company, if it is the surviving corporation, and any additional consideration
(the “Alternate Consideration”) receivable as a result of such Fundamental Transaction by a holder of the number
of shares of Common Stock for which this Warrant is exercisable immediately prior to such Fundamental Transaction (without regard
to any limitation in Section 2(e) on the exercise of this Warrant). For purposes of any such exercise, the determination of the
Exercise Price shall be appropriately adjusted to apply to such Alternate Consideration based on the amount of Alternate Consideration
issuable in respect of one share of Common Stock in such Fundamental Transaction, and the Company shall apportion the Exercise
Price among the Alternate Consideration in a reasonable manner reflecting the relative value of any different components of the
Alternate Consideration. If holders of Common Stock are given any choice as to the securities, cash or property to be received
in a Fundamental Transaction, then the Holder shall be given the same choice as to the Alternate Consideration it receives upon
any exercise of this Warrant following such Fundamental Transaction. Notwithstanding anything to the contrary, in the event of
a Fundamental Transaction, the Company or any Successor Entity (as defined below) shall, at the Holder’s option, exercisable
at any time concurrently with, or within 30 days after, the consummation of the Fundamental Transaction (or, if later, the date
of the public announcement of the applicable Fundamental Transaction), purchase this Warrant from the Holder by paying to the
Holder an amount of cash equal to the Black Scholes Value (as defined below) of the remaining unexercised portion of this Warrant
on the date of the consummation of such Fundamental Transaction; provided, however, that, if the Fundamental Transaction
is not within the Company's control, including not approved by the Company's Board of Directors, Holder shall only be entitled
to receive from the Company or any Successor Entity the same type or form of consideration (and in the same proportion), at the
Black Scholes Value of the unexercised portion of this Warrant, that is being offered and paid to the holders of Common Stock
of the Company in connection with the Fundamental Transaction, whether that consideration be in the form of cash, stock or any
combination thereof, or whether the holders of Common Stock are given the choice to receive from among alternative forms of consideration
in connection with the Fundamental Transaction; provided, further, that if holders of Common Stock of the Company
are not offered or paid any consideration in such Fundamental Transaction, such holders of Common Stock will be deemed to have
received common stock of the Successor Entity (which Entity may be the Company following such Fundamental Transaction) in such
Fundamental Transaction. “Black Scholes Value” means the value of this Warrant based on the Black-Scholes Option
Pricing Model obtained from the “OV” function on Bloomberg, L.P. (“Bloomberg”) determined as of
the day of consummation of the applicable Fundamental Transaction for pricing purposes and reflecting (A) a risk-free interest
rate corresponding to the U.S. Treasury rate for a period equal to the time between the date of the public announcement of the
applicable Fundamental Transaction and the Termination Date, (B) an expected volatility equal to the greater of 100% and the 100
day volatility obtained from the HVT function on Bloomberg (determined utilizing a 365 day annualization factor) as of the Trading
Day immediately following the public announcement of the applicable Fundamental Transaction, (C) the underlying price per share
used in such calculation shall be the greater of (i) the sum of the price per share being offered in cash, if any, plus the value
of any non-cash consideration, if any, being offered in such Fundamental Transaction and (ii) the greater of (x) the last VWAP
immediately prior to the public announcement of such Fundamental Transaction and (y) the last VWAP immediately prior to the consummation
of such Fundamental Transaction and (D) a remaining option time equal to the time between the date of the public announcement
of the applicable Fundamental Transaction and the Termination Date. The payment of the Black Scholes Value will be made by wire
transfer of immediately available funds (or such other consideration) within five Business Days of the Holder’s election
(or, if later, on the date of consummation of the Fundamental Transaction). The Company shall cause any successor entity in a
Fundamental Transaction in which the Company is not the survivor (the “Successor Entity”) to assume in writing
all of the obligations of the Company under this Warrant in accordance with the provisions of this Section 3(e) pursuant to written
agreements in form and substance reasonably satisfactory to the Holder and approved by the Holder (without unreasonable delay)
prior to such Fundamental Transaction and shall, at the option of the Holder, deliver to the Holder in exchange for this Warrant
a security of the Successor Entity evidenced by a written instrument substantially similar in form and substance to this Warrant
which is exercisable for a corresponding number of shares of capital stock of such Successor Entity (or its parent entity) equivalent
to the shares of Common Stock acquirable and receivable upon exercise of this Warrant (without regard to any limitations on the
exercise of this Warrant) prior to such Fundamental Transaction, and with an exercise price which applies the exercise price hereunder
to such shares of capital stock (but taking into account the relative value of the shares of Common Stock pursuant to such Fundamental
Transaction and the value of such shares of capital stock, such number of shares of capital stock and such exercise price being
for the purpose of protecting the economic value of this Warrant immediately prior to the consummation of such Fundamental Transaction),
and which is reasonably satisfactory in form and substance to the Holder. Upon the occurrence of any such Fundamental Transaction,
the Successor Entity shall succeed to, and be substituted for (so that from and after the date of such Fundamental Transaction,
the provisions of this Warrant referring to the “Company” shall refer instead to the Successor Entity), and may exercise
every right and power of the Company and shall assume all of the obligations of the Company under this Warrant with the same effect
as if such Successor Entity had been named as the Company herein.

 

    10

     

    

 

e) Calculations.
All calculations under this Section 3 shall be made to the nearest cent or the nearest 1/100th of a share, as the case may be.
For purposes of this Section 3, the number of shares of Common Stock deemed to be issued and outstanding as of a given date shall
be the sum of the number of shares of Common Stock (excluding treasury shares, if any) issued and outstanding.

 

f) Notice
to Holder.

 

i. Adjustment
to Exercise Price. Whenever the Exercise Price is adjusted pursuant to any provision of this Section 3, the Company shall promptly
deliver to the Holder by facsimile or email a notice setting forth the Exercise Price after such adjustment and any resulting adjustment
to the number of Warrant Shares and setting forth a brief statement of the facts requiring such adjustment.

 

ii. Notice
to Allow Exercise by Holder. If (A) the Company shall declare a dividend (or any other distribution in whatever form) on the
Common Stock, (B) the Company shall declare a special nonrecurring cash dividend on or a redemption of the Common Stock, (C) the
Company shall authorize the granting to all holders of the Common Stock rights or warrants to subscribe for or purchase any shares
of capital stock of any class or of any rights, (D) the approval of any stockholders of the Company shall be required in connection
with any reclassification of the Common Stock, any consolidation or merger to which the Company (or any of its Subsidiaries) is
a party, any sale or transfer of all or substantially all of its assets, or any compulsory share exchange whereby the Common Stock
is converted into other securities, cash or property, or (E) the Company shall authorize the voluntary or involuntary dissolution,
liquidation or winding up of the affairs of the Company, then, in each case, the Company shall cause to be delivered by facsimile
or email to the Holder at its last facsimile number or email address as it shall appear upon the Warrant Register of the Company,
at least 10 calendar days prior to the applicable record or effective date hereinafter specified, a notice stating (x) the date
on which a record is to be taken for the purpose of such dividend, distribution, redemption, rights or warrants, or if a record
is not to be taken, the date as of which the holders of the Common Stock of record to be entitled to such dividend, distributions,
redemption, rights or warrants are to be determined or (y) the date on which such reclassification, consolidation, merger, sale,
transfer or share exchange is expected to become effective or close, and the date as of which it is expected that holders of the
Common Stock of record shall be entitled to exchange their shares of the Common Stock for securities, cash or other property deliverable
upon such reclassification, consolidation, merger, sale, transfer or share exchange; provided that the failure to deliver such
notice or any defect therein or in the delivery thereof shall not affect the validity of the corporate action required to be specified
in such notice. To the extent that any notice provided in this Warrant constitutes, or contains, material, non-public information
regarding the Company or any of its Subsidiaries, the Company shall simultaneously file such notice with the Commission pursuant
to a Current Report on Form 8-K. The Holder shall remain entitled to exercise this Warrant during the period commencing on the
date of such notice to the effective date of the event triggering such notice except as may otherwise be expressly set forth herein.

 

g) Voluntary
Adjustment By Company. Subject to the rules and regulations of the Trading Market, the Company may at any time during the term
of this Warrant, subject to the prior written consent of the Holder, reduce the then current Exercise Price to any amount and for
any period of time deemed appropriate by the board of directors of the Company.

 

Section 4. Transfer
of Warrant.

 

a) Transferability.
Subject to compliance with any applicable securities laws and the conditions set forth in Section 4(d) hereof, this Warrant and
all rights hereunder (including, without limitation, any registration rights) are transferable, in whole or in part, upon surrender
of this Warrant at the principal office of the Company or its designated agent, together with a written assignment of this Warrant
substantially in the form attached hereto duly executed by the Holder or its agent or attorney and funds sufficient to pay any
transfer taxes payable upon the making of such transfer. Upon such surrender and, if required, such payment, the Company shall
execute and deliver a new Warrant or Warrants in the name of the assignee or assignees, as applicable, and in the denomination
or denominations specified in such instrument of assignment, and shall issue to the assignor a new Warrant evidencing the portion
of this Warrant not so assigned, and this Warrant shall promptly be cancelled. Notwithstanding anything herein to the contrary,
the Holder shall not be required to physically surrender this Warrant to the Company unless the Holder has assigned this Warrant
in full, in which case, the Holder shall surrender this Warrant to the Company within three (3) Trading Days of the date on which
the Holder delivers an assignment form to the Company assigning this Warrant in full. The Warrant, if properly assigned in accordance
herewith, may be exercised by a new holder for the purchase of Warrant Shares without having a new Warrant issued.

 

    11

     

    

 

b) New
Warrants. This Warrant may be divided or combined with other Warrants upon presentation hereof at the aforesaid office of the
Company, together with a written notice specifying the names and denominations in which new Warrants are to be issued, signed by
the Holder or its agent or attorney. Subject to compliance with Section 4(a), as to any transfer which may be involved in such
division or combination, the Company shall execute and deliver a new Warrant or Warrants in exchange for the Warrant or Warrants
to be divided or combined in accordance with such notice. All Warrants issued on transfers or exchanges shall be dated the initial
issuance date of this Warrant and shall be identical with this Warrant except as to the number of Warrant Shares issuable pursuant
thereto.

 

c) Warrant
Register. The Company shall register this Warrant, upon records to be maintained by the Company for that purpose (the “Warrant
Register”), in the name of the record Holder hereof from time to time. The Company may deem and treat the registered
Holder of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution to the Holder, and
for all other purposes, absent actual notice to the contrary.

 

d) Transfer
Restrictions. If, at the time of the surrender of this Warrant in connection with any transfer of this Warrant, the transfer
of this Warrant shall not be either (i) registered pursuant to an effective registration statement under the Securities Act and
under applicable state securities or blue sky laws or (ii) eligible for resale without volume or manner-of-sale restrictions or
current public information requirements pursuant to Rule 144 promulgated under the Securities Act, the Company may require, as
a condition of allowing such transfer, that the Holder or transferee of this Warrant, as the case may be, to deliver a legal opinion
of counsel to the transferor to the effect that the transfer is pursuant to an effective registration statement under the Securities
Act or pursuant to an available exemption from, or is a transaction not subject to, the registration requirements of the Securities
Act and is in accordance with applicable state securities laws.

 

e) Representation
by the Holder. The Holder, by the acceptance hereof, represents and warrants that it is acquiring this Warrant and, upon any
exercise hereof, will acquire the Warrant Shares issuable upon such exercise, for its own account and not with a view to or for
distributing or reselling such Warrant Shares or any part thereof in violation of the Securities Act or any applicable state securities
law, except pursuant to sales registered or exempted under the Securities Act.

 

Section 5. Miscellaneous.

 

a) No
Rights as Stockholder Until Exercise; No Settlement in Cash. This Warrant does not entitle the Holder to any voting rights,
dividends or other rights as a stockholder of the Company prior to the exercise hereof as set forth in Section 2(d)(i), except
as expressly set forth in Section 3. Without limiting any rights of a Holder to receive Warrant Shares on a “cashless exercise”
pursuant to Section 2(c) or to receive cash payments pursuant to Section 2(d)(i) and Section 2(d)(iv) herein, in no event shall
the Company be required to net cash settle an exercise of this Warrant.

 

    12

     

    

 

b) Loss,
Theft, Destruction or Mutilation of Warrant. The Company covenants that upon receipt by the Company of evidence reasonably
satisfactory to it of the loss, theft, destruction or mutilation of this Warrant or any stock certificate relating to the Warrant
Shares, and in case of loss, theft or destruction, of indemnity or security reasonably satisfactory to it (which, in the case of
the Warrant, shall not include the posting of any bond), and upon surrender and cancellation of such Warrant or stock certificate,
if mutilated, the Company will make and deliver a new Warrant or stock certificate of like tenor and dated as of such cancellation,
in lieu of such Warrant or stock certificate.

 

c) Saturdays,
Sundays, Holidays, etc. If the last or appointed day for the taking of any action or the expiration of any right required or
granted herein shall not be a Business Day, then such action may be taken or such right may be exercised on the next succeeding
Business Day.

 

d) Authorized
Shares.

 

The Company covenants
that, during the period the Warrant is outstanding, it will reserve from its authorized and unissued Common Stock a sufficient
number of shares to provide for the issuance of the Warrant Shares upon the exercise of any purchase rights under this Warrant.
The Company further covenants that its issuance of this Warrant shall constitute full authority to its officers who are charged
with the duty of issuing the necessary Warrant Shares upon the exercise of the purchase rights under this Warrant. The Company
will take all such reasonable action as may be necessary to assure that such Warrant Shares may be issued as provided herein without
violation of any applicable law or regulation, or of any requirements of the Trading Market upon which the Common Stock may be
listed. The Company covenants that all Warrant Shares which may be issued upon the exercise of the purchase rights represented
by this Warrant will, upon exercise of the purchase rights represented by this Warrant and payment for such Warrant Shares in accordance
herewith, be duly authorized, validly issued, fully paid and nonassessable and free from all taxes, liens and charges created by
the Company in respect of the issue thereof (other than taxes in respect of any transfer occurring contemporaneously with such
issue).

 

Except and
to the extent as waived or consented to by the Holder, the Company shall not by any action, including, without limitation, amending
its certificate of incorporation or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue or
sale of securities or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this
Warrant, but will at all times in good faith assist in the carrying out of all such terms and in the taking of all such actions
as may be necessary or appropriate to protect the rights of Holder as set forth in this Warrant against impairment. Without limiting
the generality of the foregoing, the Company will (i) not increase the par value of any Warrant Shares above the amount payable
therefor upon such exercise immediately prior to such increase in par value, (ii) take all such action as may be necessary or appropriate
in order that the Company may validly and legally issue fully paid and nonassessable Warrant Shares upon the exercise of this Warrant
and (iii) use commercially reasonable efforts to obtain all such authorizations, exemptions or consents from any public regulatory
body having jurisdiction thereof, as may be, necessary to enable the Company to perform its obligations under this Warrant.

 

    13

     

    

 

Before taking
any action which would result in an adjustment in the number of Warrant Shares for which this Warrant is exercisable or in the
Exercise Price, the Company shall obtain all such authorizations or exemptions thereof, or consents thereto, as may be necessary
from any public regulatory body or bodies having jurisdiction thereof.

 

e) Governing
Law. All questions concerning the construction, validity, enforcement and interpretation of this Warrant shall be governed
by and construed and enforced in accordance with the internal laws of the State of New York, without regard to the principles of
conflicts of law thereof. Each party agrees that all legal proceedings concerning the interpretations, enforcement and defense
of the transactions contemplated by this Warrant (whether brought against a party hereto or their respective affiliates, directors,
officers, shareholders, partners, members, employees or agents) shall be commenced exclusively in the state and federal courts
sitting in the City of New York. Each party hereby irrevocably submits to the exclusive jurisdiction of the state and federal courts
sitting in the City of New York, Borough of Manhattan for the adjudication of any dispute hereunder or in connection herewith or
with any transaction contemplated hereby or discussed herein, and hereby irrevocably waives, and agrees not to assert in any suit,
action or proceeding, any claim that it is not personally subject to the jurisdiction of any such court, that such suit, action
or proceeding is improper or is an inconvenient venue for such proceeding. Each party hereby irrevocably waives personal service
of process and consents to process being served in any such suit, action or proceeding by mailing a copy thereof via registered
or certified mail or overnight delivery (with evidence of delivery) to such party at the address in effect for notices to it under
this Warrant and agrees that such service shall constitute good and sufficient service of process and notice thereof. Nothing contained
herein shall be deemed to limit in any way any right to serve process in any other manner permitted by law. If either party shall
commence an action, suit or proceeding to enforce any provisions of this Warrant, the prevailing party in such action, suit or
proceeding shall be reimbursed by the other party for their reasonable attorneys’ fees and other costs and expenses incurred
with the investigation, preparation and prosecution of such action or proceeding.

 

f) Restrictions.
The Holder acknowledges that the Warrant Shares acquired upon the exercise of this Warrant, if not registered, and the Holder does
not utilize cashless exercise, will have restrictions upon resale imposed by state and federal securities laws.

 

    14

     

    

 

g) Nonwaiver
and Expenses. No course of dealing or any delay or failure to exercise any right hereunder on the part of Holder shall operate
as a waiver of such right or otherwise prejudice the Holder’s rights, powers or remedies. Without limiting any other provision
of this Warrant, if the Company willfully and knowingly fails to comply with any provision of this Warrant, which results in any
material damages to the Holder, the Company shall pay to the Holder such amounts as shall be sufficient to cover any costs and
expenses including, but not limited to, reasonable attorneys’ fees, including those of appellate proceedings, incurred by
the Holder in collecting any amounts due pursuant hereto or in otherwise enforcing any of its rights, powers or remedies hereunder.

 

h) Notices.
Any and all notices or other communications or deliveries to be provided by the Holders hereunder including, without limitation,
any Notice of Exercise, shall be in writing and delivered personally, by e-mail, or sent by a nationally recognized overnight courier
service, addressed to the Company, at 1455 Adams Dr., Suite 2050, Menlo Park, CA 94025, Attention: Chief Financial Officer, email
address: jeff.biunno@cohbar.com, or such other email address or address as the Company may specify for such purposes by notice
to the Holders. Any and all notices or other communications or deliveries to be provided by the Company hereunder shall be in writing
and delivered personally, by e-mail, or sent by a nationally recognized overnight courier service addressed to each Holder at the
e-mail address or address of such Holder appearing on the books of the Company. Any notice or other communication or deliveries
hereunder shall be deemed given and effective on the earliest of (i) the time of transmission, if such notice or communication
is delivered via e-mail at the e-mail address set forth in this Section prior to 5:30 p.m. (New York City time) on any date, (ii)
the next Trading Day after the time of transmission, if such notice or communication is delivered via e-mail at the e-mail address
set forth in this Section on a day that is not a Trading Day or later than 5:30 p.m. (New York City time) on any Trading Day, (iii)
the second Trading Day following the date of mailing, if sent by U.S. nationally recognized overnight courier service, or (iv)
upon actual receipt by the party to whom such notice is required to be given.

 

i) Limitation
of Liability. No provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant to purchase
Warrant Shares, and no enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of the Holder
for the purchase price of any Common Stock or as a stockholder of the Company, whether such liability is asserted by the Company
or by creditors of the Company.

 

j) Remedies.
The Holder, in addition to being entitled to exercise all rights granted by law, including recovery of damages, will be entitled
to specific performance of its rights under this Warrant. The Company agrees that monetary damages would not be adequate compensation
for any loss incurred by reason of a breach by it of the provisions of this Warrant and hereby agrees to waive and not to assert
the defense in any action for specific performance that a remedy at law would be adequate.

 

k) Successors
and Assigns. Subject to applicable securities laws, this Warrant and the rights and obligations evidenced hereby shall inure
to the benefit of and be binding upon the successors and permitted assigns of the Company and the successors and permitted assigns
of Holder. The provisions of this Warrant are intended to be for the benefit of any Holder from time to time of this Warrant and
shall be enforceable by the Holder or holder of Warrant Shares.

 

l) Amendment.
This Warrant may be modified or amended or the provisions hereof waived with the written consent of the Company, on the one hand,
and the Holder or the beneficial owner of this Warrant, on the other hand.

 

m) Severability.
Wherever possible, each provision of this Warrant shall be interpreted in such manner as to be effective and valid under applicable
law, but if any provision of this Warrant shall be prohibited by or invalid under applicable law, such provision shall be ineffective
to the extent of such prohibition or invalidity, without invalidating the remainder of such provisions or the remaining provisions
of this Warrant.

 

n) Headings.
The headings used in this Warrant are for the convenience of reference only and shall not, for any purpose, be deemed a part of
this Warrant.

 

********************

 

(Signature Page Follows)

 

 

    15

     

    

 

IN WITNESS WHEREOF, the
Company has caused this Warrant to be executed by its officer thereunto duly authorized as of the date first above indicated.

 

	 	
        Cohbar,
inc. 

	 	 
	 	By:	     
	 		Name:	 
	 		Title:	 

 

    16

     

    

 

NOTICE OF EXERCISE

 

To: cohbar,
inc.

 

(1) The
undersigned hereby elects to purchase ________ Warrant Shares of the Company pursuant to the terms of the attached Warrant (only
if exercised in full), and tenders herewith payment of the exercise price in full, together with all applicable transfer taxes,
if any.

 

(2) Payment
shall take the form of (check applicable box):

 

☐ in lawful
money of the United States; or

 

 ☐
if permitted the cancellation of such number of Warrant Shares as is necessary, in accordance with the formula set forth in
subsection 2(c), to exercise this Warrant with respect to the maximum number of Warrant Shares purchasable pursuant to the
cashless exercise procedure set forth in subsection 2(c).

 

(3) Please
issue said Warrant Shares in the name of the undersigned or in such other name as is specified below:

 

_______________________________

 

 

The Warrant Shares shall be delivered to
the following DWAC Account Number:

 

_______________________________

 

_______________________________

 

_______________________________

 

(4) The undersigned is
an “accredited investor” as defined in Regulation D promulgated under the Securities Act of 1933, as amended.

 

[SIGNATURE
OF HOLDER]

 

Name of Investing Entity: ________________________________________________________________________

Signature of Authorized Signatory of
Investing Entity: _________________________________________________

Name of Authorized Signatory: ___________________________________________________________________

Title of Authorized Signatory: ____________________________________________________________________

Date: ________________________________________________________________________________________

 

    17

     

    

 

ASSIGNMENT FORM

 

(To assign the
foregoing Warrant, execute this form and supply required information. Do not use this form to purchase shares.)

 

FOR VALUE RECEIVED,
the foregoing Warrant and all rights evidenced thereby are hereby assigned to

 

	
         Name:
	 
	 	(Please Print)
	 	 
	Address:	 
	 	(Please Print)
	Phone Number:	
	 	 
	Email Address:             	
	 	 
	Dated: _________________, ______	 
	 	 
	Holder’s Signature: 	 
	 	 
	Holder’s Address: 	 

 

 

18Exhibit 10.1

 

SUBSCRIPTION AGREEMENT

 

THIS SUBSCRIPTION
AGREEMENT (the “Agreement”) by and between CohBar, Inc., a Delaware corporation (the “Company”),
and the undersigned individual, corporation, limited liability company, partnership, trust or employee benefit plan executing this
Agreement as the investor (the “Investor”), provides as follows:

 

Recitals

 

A. This
Agreement is made in connection with the Company’s offering (the “Offering”) of units (the “Units”),
each consisting of one share of the Company’s common stock, par value $0.001 per share (“Common Stock”)
and one warrant to purchase 0.75 shares of Common Stock (together with the shares underlying the Units, the “Shares”)
in substantially the form attached hereto as Exhibit A (the “Warrants”).

 

B. The
Company wishes to sell to the Investor and the Investor wishes to purchase from the Company the number of Units specified on the
signature page hereof at the price per Unit set forth in Section 2 hereof, subject to the terms, conditions, and requirements contained
in this Agreement.

 

C. The
Investor understands that the Company has the right, in its sole discretion, to refuse to accept the Investor’s subscription
in whole or in part at any time and for any reason, including without limitation the Company’s belief that the Investor does
not meet the applicable suitability requirements for participation in the Offering or that the investment is otherwise unsuitable
for the Investor.

 

NOW, THEREFORE, in consideration
of the foregoing and the promises and covenants contained in this Agreement, the Company and the Investor hereby agree as follows:

 

1. Sale
of Units. In accordance with the terms and conditions of this Agreement, the Company hereby agrees to sell to the Investor,
and the Investor hereby agrees to purchase from the Company, on or before December 18, 2020 (the “Closing Date”),
the number of Units indicated on the signature page hereof. The obligation of the Company to sell the Units to the Investor is
subject to, among other things, the conditions that: (i) the Company shall have received approval for the sale of the Units from
The Nasdaq Stock Market LLC (“Nasdaq”); and (ii) all other necessary regulatory approvals shall have been obtained
prior to the Closing Date.

 

2. Purchase
Price. The purchase price (“Purchase Price”) for each Unit shall be USD$1.22. The Purchase Price payable
for the Units to be purchased by the Investor shall be paid by the forgiveness by the Investor of all outstanding principal and
interest due to the Investor by the Company under the Company’s 8% Unsecured Promissory Notes Due 2021, as amended (the “Investor
Note”), as indicated on the Investor’s signature page hereto. Additionally, the Investor shall have delivered with
this executed Agreement prior to the Closing:

 

		2.1	a completed Investor Questionnaire (the “Investor Questionnaire”) attached hereto as Exhibit B and,
if the Investor is a resident of Canada and is:

 

		2.1.1	an Accredited Investor by virtue of the fact that the Investor falls within one or more of the
sub-paragraphs of the definition of Accredited Investor (a “Canadian Accredited Investor”) set out in the Canadian
Accredited Investor Certificate (the “Canadian Accredited Investor Certificate”) attached hereto as Exhibit
C:

 

		2.1.1.1	a completed Canadian Accredited Investor Certificate; and

 

		2.1.1.2	if the Investor is an individual described in category (j), (k) or (l) of the Canadian Accredited
Investor Certificate, a completed Form 45-106F9 - Form for Individual Accredited Investors, attached hereto as Exhibit
D;

 

     

     

    

		2.2	a completed Note Termination Agreement in the form attached hereto as Exhibit F if the Investor
is paying the Purchase Price by the forgiveness of all principal and interest outstanding under the Investor Note; and

 

		2.3	any other further documentation as required under the applicable securities laws or stock exchange
or other regulatory authority.

 

Subscriptions for Units may be accepted or rejected
by the Company for any or no reason in its sole discretion.

 

3. Representations
and Warranties of Investor. The Investor represents and warrants to the Company as follows (which such representations and
warranties shall survive the Closing Date):

 

		3.1	He, she or it has answered the questions contained in the Investor Questionnaire and, as applicable,
the Canadian Accredited Investor Certificate and the Form 45-106F9 - Form for Individual Accredited Investors (collectively,
the “Canadian Exemption Certifications”), and made a part hereof to the best of his, her or its knowledge and
the answers thereto are complete and accurate. The Investor understands and agrees that, although such answers will be kept strictly
confidential, the Company may present such Investor Questionnaire and, if applicable, the Canadian Exemption Certifications to
such parties as it deems advisable if called upon to establish the availability under applicable securities laws of an exemption
from registration. The Investor agrees to indemnify the Company, its agents, officers, directors and shareholders, for any and
all losses (including without limitation attorneys’ fees and other costs of investigating, prosecuting, or defending any
litigation claim) incurred by the Company as a result of its reliance on the representations and warranties of the Investor made
in this Agreement or any answers contained in the Investor Questionnaire and, if applicable, the Canadian Exemption Certifications.

 

		3.2	If the Investor is a corporation, limited liability company, partnership, trust, or employee benefit
plan, it is authorized to make the investment contemplated herein, and the person signing this Agreement on behalf of such entity
has been duly authorized by such entity to do so.

 

		3.3	This Agreement has been duly authorized, executed and delivered by the Investor and constitutes
the Investor’s legal, valid and binding obligation enforceable in accordance with its terms.

 

		3.4	The Investor is acquiring the Units as principal for the Investor’s own account for investment
and not with a view to resale or distribution. The Investor understands that the Shares and the Warrants have not been, and will
not be, registered under the Securities Act of 1933, as amended (the “1933 Act”), or applicable securities laws
by reason of specific exemptions from the registration provisions of the 1933 Act and applicable state securities laws that depend
upon, among other things, the bona fide nature of the investment intent and the accuracy of the Investor’s representations
and warranties as expressed in this Agreement and in the Investor Questionnaire.

 

		3.5	The Company has advised the Investor, if the Investor is a resident of Canada, that the Company
is relying on an exemption from the requirements under applicable Canadian securities laws to provide the Investor with a prospectus
and that no prospectus has been filed by the Company with any securities commission in Canada in connection with the Offering,
and as a consequence:

 

		3.5.1	the Investor is restricted from using most of the civil remedies available under applicable Canadian
securities laws and certain protections, rights and remedies provided by applicable Canadian securities laws, including statutory
rights of rescission or damages, will not be available to the Investor;

 

		3.5.2	the Investor may not receive information that would otherwise be required to be provided to the
Investor under the applicable Canadian securities laws; and

    	 	2	 

     

    

		3.5.3	the Investor is relieved from certain obligations that would otherwise apply under the applicable Canadian securities laws.

 

		3.6	The Investor: (i) has been furnished, has carefully read, understands the terms and conditions
of, and the information contained in, this Agreement (including all exhibits and all amendments thereto and hereto) and (ii) has
been given the opportunity to ask questions of, and receive answers from, the Company concerning the terms and conditions of this
Agreement, the Units, the Company and its business.

 

		3.7	The Investor recognizes that (i) the purchase of the Units involves a high degree of risk and has
taken full cognizance of and understands such risks, (ii) that all information provided, if any, by the Company relating to its
use of proceeds, financial forecasts, and other information which is not of an historical nature (“Forward-looking Information”),
represents only the Company’s good faith assessment of such Forward-looking Information, and is based upon assumptions which
the Company believes are reasonable, although no assurance exists that such Forward-looking Information is accurate or will be
fulfilled, and (iii) that the Company has relied on the representations of the Investor as set forth in this Agreement, in the
Investor Questionnaire and, if applicable, the Canadian Accredited Investor Certificate, in determining materiality for purposes
of satisfying the disclosure obligations of the Company and in determining the availability of exemptions from (a) registration
requirements under applicable United States federal and state securities laws; and (b) prospectus requirements under applicable
Canadian securities laws.

 

		3.8	The Investor is resident in the jurisdiction set out on the execution page of the Investor Questionnaire,
which such address is the Investor’s residence or principal place of business, and such address was not obtained or used
solely for the purpose of acquiring the Units.

 

		3.9	Neither (a) the Investor nor (b) if the Investor is a Covered Person (as defined below), any person
or entity with whom such Purchaser shares beneficial ownership of the Company’s securities, is subject to any “bad
actor” disqualifying event described in Rule 506(d)(1)(i)-(viii) of the Securities Act (a “Disqualification Event”),
except for Disqualification Events covered by Rule 506(d)(2)(ii) or (iii) or (d)(3) under the Securities Act and disclosed reasonably
in advance of the Closing in writing in reasonable detail to the Company. For purposes hereof, a “Covered Persons”
is any Person specified in Rule 506(d)(1) under the Securities Act, including the Company; any predecessor or affiliate of the
Company; any director, executive officer or other officer participating in the sale of the Units; any beneficial owner of 20% or
more of the Company’s outstanding voting equity securities, calculated on the basis of voting power; any promoter (as defined
in Rule 405 under the Securities Act) connected with the Company in any capacity at the time of the sale of the Stock; and any
person that has been or will be paid (directly or indirectly) remuneration for solicitation of purchasers in connection with the
sale of the Stock (a “Solicitor”), any general partner or managing member of any Solicitor, and any director,
executive officer or other officer participating in the sale of the Stock of any Solicitor or general partner or managing member
of any Solicitor.

 

		3.10	The Investor fully understands and agrees that the Investor must bear the economic risk of the
purchase of the Units, including the Shares and the Warrants, for an indefinite period of time because, among other reasons, neither
the Units, Shares nor the Warrants have been registered under the 1933 Act, or the securities laws of any state, and therefore
cannot be sold, pledged, assigned or otherwise disposed of unless they are subsequently registered under the 1933 Act and applicable
state securities laws or exemptions from such registration requirements are available. The Investor further understands and agrees
that the Company will not honor any attempt by the Investor to sell, pledge, transfer, or otherwise dispose of all or any portion
of the Shares in the absence of an effective registration statement under the 1933 Act and applicable state securities laws or
an unqualified opinion of counsel, satisfactory in form and substance to the Company and its counsel, and obtained at the expense
of the Investor, that exemptions are available therefrom with respect to such attempted disposition.

    	 	3	 

     

    

		3.11	The Investor acknowledges that the certificates representing the Shares and Warrants will bear
a legend as of the Closing Date substantially in the following form:

 

THESE SECURITIES HAVE NOT
BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), OR UNDER THE SECURITIES LAWS OF ANY STATE.
THESE SECURITIES MAY NOT BE OFFERED, SOLD OR OTHERWISE TRANSFERRED, PLEDGED OR HYPOTHECATED EXCEPT AS PERMITTED UNDER THE ACT AND
APPLICABLE STATE SECURITIES LAWS IN ACCORDANCE WITH APPLICABLE REGISTRATION REQUIREMENTS OR AN EXEMPTION THEREFROM. THE ISSUER
OF THESE SECURITIES MAY REQUIRE AN OPINION OF COUNSEL REASONABLY SATISFACTORY TO THE ISSUER THAT SUCH OFFER, SALE, TRANSFER, PLEDGE
OR HYPOTHECATION OTHERWISE COMPLIES WITH THE ACT AND ANY APPLICABLE STATE SECURITIES LAWS.

 

WITHOUT COMPLIANCE WITH ALL
APPLICABLE SECURITIES LEGISLATION, THE SECURITIES REPRESENTED BY THIS CERTIFICATE MAY NOT BE SOLD, TRANSFERRED, HYPOTHECATED OR
OTHERWISE TRADED IN CANADA OR TO OR FOR THE BENEFIT OF A CANADIAN RESIDENT UNTIL [FOUR MONTHS FROM THE DATE OF CLOSING]

 

The Investor, if a resident of
Canada, acknowledges that the certificates representing the Shares and Warrants will bear a legend as of the Closing Date substantially
in the following form (and with the necessary information inserted):

 

UNLESS PERMITTED UNDER SECURITIES
LEGISLATION, THE HOLDER OF THIS SECURITY MUST NOT TRADE THE SECURITY BEFORE THE DATE THAT IS 4 MONTHS AND A DAY AFTER [INSERT THE
DISTRIBUTION DATE].

 

		3.12	The Investor (i) can bear the risk of losing the entire investment in the Units; (ii) has overall
commitments to other investments which are not readily marketable that are not disproportionate to his, her or its net worth and
the investment in the Shares will not cause such overall commitments to become excessive; (iii) has adequate means of providing
for current needs and personal contingencies and has no need for liquidity in the investment in the Units; and (iv) has sufficient
knowledge and experience in financial and business matters such that he, she or it is capable, either alone, or together with one
or more advisors, of evaluating the risks and merits of investing in the Units.

 

		3.13	The Investor has not incurred, and will not incur, directly or indirectly, as a result of any action
taken by the Investor, any liability for brokerage or finder’s fees or agent’s commissions or any similar charges in
connection with this Agreement.

 

		3.14	The Investor acknowledges that he, she or it must depend entirely upon his, her or its own personal
advisors for tax advice concerning an investment in the Company, that the Company has not provided any information on tax matters,
and that any information provided to the Investor by, or on behalf of, the Company is not to be construed as tax advice to the
Investor from the Company or counsel to the Company. The Investor will rely solely on his, her or its own personal advisors and
not on any statements or representations of the Company or any of its agents and understands that the Investor (and not the Company)
shall be responsible for the Investor’s own tax liability that may arise as a result of this investment or the transactions
contemplated by this Agreement.

 

		3.15	The Investor understands and agrees that the Company is issuing the Units to him, her or it pursuant
to the exemptions from federal and state securities registration requirements under the 1933 Act. In connection therewith, the
Investor represents and warrants that the Investor qualifies as an “accredited investor” as such term is defined under
Rule 501 of the 1933 Act (a “U.S. Accredited Investor”) and has confirmed that on the Investor Questionnaire
attached hereto as Exhibit C.

    	 	4	 

     

    

		3.16	If a resident of Canada, the Investor also represents and warrants that the Investor:

 

		3.16.1	qualifies as an “accredited investor” as such term is defined in NI 45-106 (a “Canadian
Accredited Investor”), and has confirmed that on the Canadian Accredited Investor Certificate attached hereto as Exhibit
D and that the Investor was not created or used solely to purchase or hold securities as an Accredited Investor as described
in paragraph (m) of the definition of Accredited Investor set out in Exhibit D; or

 

		3.16.2	is not an individual and purchases as principal such number of Units having an acquisition cost
to the Investor of not less than Cdn$150,000 paid in cash at the time of Closing, such Investor also represents and warrants that
the Investor was not created, or is used, solely to purchase or hold securities in reliance on the exemption from the prospectus
requirement set out in subsection 2.10(1) of NI 45-106.

 

		3.17	The Investor agrees to comply with all securities laws and with the policies of Nasdaq concerning
the purchase of, the holding of, and the resale restrictions applicable to, the Shares and the Warrants. The Investor recognizes
that the securities laws and regulations of certain jurisdictions, which may include the jurisdiction of which the Investor is
a resident, may impose additional requirements relating to this Offering and the Investor’s purchase of the Shares and the
Warrants. The Investor hereby agrees to execute and to comply with the terms of any additions, supplements or amendments to this
Agreement which are required by the Company.

 

		3.18	The funds representing the aggregate purchase price in respect of the Units which will be advanced
by the Investor to the Company hereunder will not represent proceeds of crime for the purpose of the Proceeds of Crime (Money Laundering)
and Terrorist Financing Act (Canada) (the “PCMLTF Act”) and the Investor acknowledges that the Company may in
the future be required by law to disclose the Investor’s name and other information relating to this Agreement and the Investor’s
subscription hereunder, on a confidential basis, pursuant to the PCMLTF Act; to the best of the Investor’s knowledge, none
of the subscription funds to be provided hereunder (i) have been or will be obtained or derived, directly or indirectly, from or
related to any activity that is deemed illegal under the laws of Canada or the United States or any other jurisdiction, or (ii)
are being tendered on behalf of a person or entity who has not been identified to the Investor; the Investor shall promptly notify
the Company if he discovers that any such representation ceases to be true, and shall provide the Company with appropriate information
in connection therewith.

 

		3.19	The Investor acknowledges that no agency, stock exchange or governmental agency, securities commission
or similar regulatory authority or other entity has reviewed or passed on or made any finding or determination as to the merits
of or made any recommendation or endorsement with respect to the Shares and the Warrants.

 

		3.20	There is no government or other insurance covering the Shares or the Warrants.

 

		3.21	The Investor has no knowledge of a “material fact” or “material change”
(as those terms are defined in applicable Canadian securities laws or under the 1933 Act, as applicable) in the affairs of the
Company that has not been generally disclosed to the public, save knowledge of this particular transaction.

 

		3.22	The Investor’s decision to tender this offer and purchase the Units has not been made as
a result of any verbal or written representation as to fact or otherwise made by or on behalf of the Company or any other person
and is based entirely upon this Agreement and currently available public information concerning the Company.

 

		3.23	The representations and warranties made in this Agreement, the Investor Questionnaire and, if applicable,
the Canadian Exemption Certifications, as well as all other information that the Investor has provided to the Company, either directly
or indirectly, concerning the Investor’s financialposition and knowledge of financial
and business matters, is correct and complete as of the date hereof, and if there should be any material change in such information
prior to the issuance to Investor of the Shares, Investor will immediately notify the Company.

 

    	 	5	 

     

    

 

4. Representations
and Warranties of the Company. The Company represents and warrants to the Investor as follows (which such representations and
warranties shall survive the Closing Date):

 

		4.1	The Company is a corporation duly organized, validly existing and in good standing under the laws
of the State of Delaware. The Company has the requisite corporate power and authority to own and operate its properties and assets,
to carry on its business as presently conducted or proposed to be conducted, to execute and deliver the Agreement, to issue and
sell the Units and to perform its obligations pursuant to the Agreement. The Company is presently qualified to do business as a
foreign corporation in each jurisdiction where the failure to be so qualified could reasonably be expected to have a material adverse
effect on the Company’s financial condition or business as now conducted or proposed to be conducted.

 

		4.2	All corporate action on the part of the Company and its directors, officers and stockholders necessary
for the authorization, execution and delivery of the Agreement by the Company, the authorization, sale, issuance (or reservation
for issuance) and delivery of the Units, and the performance of all of the Company’s obligations under the Agreement has
been taken or will be taken prior to the Closing. The Agreement, when executed and delivered by the Company, shall constitute a
valid and binding obligation of the Company, enforceable in accordance with its terms, except (i) as limited by laws of general
application relating to bankruptcy, insolvency and the relief of debtors, and (ii) as limited by rules of law governing specific
performance, injunctive relief or other equitable remedies and by general principles of equity.

 

5. Registration.
The Company covenants to use its commercially reasonable efforts to file a registration statement on Form S-1 (or, if applicable,
Form S-3) with the Securities and Exchange Commission (the “SEC”) registering the resale in the United States
by the Investor of the Shares (the “Registration Statement”) within 35 days after the Closing. Investors who
are residents of Canada acknowledge that the Shares will be subject to a 4 month hold period in Canada under applicable Canadian
securities laws, regardless of whether or not the Company has filed and have declared effective by the SEC the Registration Statement.

 

6. Personal
Information. If the Investor is a resident of a jurisdiction of Canada and is an individual, the Investor authorizes the indirect
collection of the Personal Information by the securities regulatory authority or regulator (each as defined in National Instrument
14-101 – Definitions) and confirms that the Investor has been notified by the Company: (a) that the Company will be
delivering the Personal Information to the securities regulatory authority or regulator; (b) that the Personal Information is being
collected by the securities regulatory authority or regulator under the authority granted in applicable securities laws; (c) that
the Personal Information is being collected for the purposes of the administration and enforcement of applicable securities laws;
and (d) that the title, business address and business telephone number of the public official who can answer questions about the
securities regulatory authority’s or regulator’s indirect collection of the Personal Information is as set out in Exhibit
F.

 

7. Applicable
Law; Venue. This Agreement shall be construed in accordance with and governed by the laws of the State of Delaware without
reference to the choice of law principles of any jurisdiction. THE INVESTOR IRREVOCABLY AND UNCONDITIONALLY CONSENTS TO THE EXCLUSIVE
JURISDICTION OF THE COURTS OF THE STATE OF DELAWARE AND OF THE UNITED STATES LOCATED IN THE STATE OF DELAWARE, IN CONNECTION WITH
ANY SUIT, ACTION OR PROCEEDING RELATING TO THIS AGREEMENT OR THE OFFERING AND AGREES NOT TO COMMENCE ANY SUIT, ACTION, OR PROCEEDING
RELATING THERETO EXCEPT IN SUCH COURTS.

 

8. Binding
Effect. Except as otherwise provided herein, this Agreement shall be binding upon and inure to the benefit of the parties and
their respective heirs, executors, administrators, successors, legal representatives and assigns.

 

    	 	6	 

     

    

 

9. Notice.
All notices and other communications required or permitted hereunder or necessary or convenient in connection herewith shall be
in writing and shall be deemed to have been given three business days after the date mailed when mailed by registered or certified
mail, postage prepaid, or the next business day if sent by special courier such as FedEx (except that notice of change of address
shall be deemed given only when received), to the address shown on the Company’s records, in the case of the Investor, and
of the Company’s registered office, in the case of the Company, or to such other names or addresses as the Company or the
Investor, as the case may be, shall designate by notice to the other party in the manner specified in this Section.

 

10. Severability.
If any provision of this Agreement or application thereof to anyone or under any circumstances is adjudicated to be invalid or
unenforceable in any jurisdiction, such invalidity or unenforceability shall not affect any other provisions or applications of
this Agreement that can be given effect without the invalid or unenforceable provision or application and shall not invalidate
or render unenforceable the invalid or unenforceable provision in any other jurisdiction or under any other circumstance.

 

11. Entire
Agreement. This Agreement, and the Units purchased hereunder, constitute the entire agreement by and between the parties pertaining
to the subject matter hereof and supersede all prior and contemporaneous understandings of the parties.

 

12. Counterparts.
This Agreement may be executed in any number of counterparts, and any party hereto may execute such counterpart, each of which
when so executed and delivered shall be deemed an original and all of which taken together shall constitute one and the same instrument.
This Agreement shall become binding when either this Agreement or two or more counterparts hereto shall have been executed and
delivered by the parties hereto

 

13. Variation
in Pronouns. All pronouns shall be deemed to refer to masculine, feminine, neuter, singular, or plural, as the identity of
the person or persons may require.

 

14. Counsel.
This Agreement and all other agreements related to the Offering (the “Offering Agreements”) have been prepared
by Fenwick & West LLP, as counsel to the Company (“Counsel”), after full disclosure of its representation
of the Company and with the consent and direction of the Company and the Investor. The Investor has reviewed the contents of the
Offering Agreements and fully understands their terms. The Investor acknowledges that he, she or it is fully aware of his, her
or its right to the advice of counsel independent from that of the Company, that Counsel has advised the Investor of such right
and disclosed to the Investor the risks in not seeking such independent advice, and that he, she or it understands the potentially
adverse interests of the parties with respect to the Offering Agreements. The Investor further acknowledges that no representations
have been made with respect to the tax or other consequences of the Offering Agreements to the Investor and that he, she or it
has been advised of the importance of seeking independent counsel with respect to such consequences. By executing this Agreement,
the Investor represents that he, she or it has, after being advised of the potential conflicts between the Investor and the Company
with respect to the future consequences of the Offering Agreements, either consulted independent legal counsel or elected, notwithstanding
the advisability of seeking such independent legal counsel, not to consult such independent legal counsel.

 

[SIGNATURES APPEAR ON THE
FOLLOWING PAGES]

 

    	 	7	 

     

    

 

SIGNATURE PAGE TO SUBSCRIPTION AGREEMENT

 

IN WITNESS
WHEREOF, this Subscription Agreement has been duly executed by the duly authorized officer of the Company and the undersigned Investor
or its duly authorized signatory, as the case may be, as of the date first written beneath the signature of such officer of the
Company below.

 

	Subscription	 	Signature
	 	 	 
	Number of Units: _____________	 	 
	 	 	(Print
    or type name of the Investor exactly as securities
	Aggregate Purchase Price
    for Units : $ _____________ 

    (USD $1.22 times # of Units)	 	should be
    registered)
	 	 	 
		 	By:	       
	Social
    Security or	 	 	(Signature)
	Federal
                                Tax Identification No.: ___________________ 
	 	 	 
	 	 	 	 
	Typed or printed name
    and address of the Investor:	 	 	(Name
    of above signatory)
	 	 	 	 
	 	 	 	 
	 	 	 	(Title,
    if applicable)
	Fax
    No: ________________________________________	 	 	 
	E-mail address: __________________________________	 	 	
	Consent to receive notices by e-mail:
    Yes  ̈ No  ̈	 	 	(Additional
    Signature, if applicable, e.g., joint tenants)
	 	 	 	 
		 	 	 
	 	 	 	(Name
    of additional signatory)

	
        IMPORTANT NOTE:

         

        ALL INVESTORS MUST ALSO
COMPLETE THE INVESTOR QUESTIONNAIRE ATTACHED AS EXHIBIT B. ADDITIONALLY, INVESTORS RESIDENT IN CANADA MUST COMPLETE THE CANADIAN
ACCREDITED INVESTOR CERTIFICATE ATTACHED AS EXHIBIT C AND, IF APPLICABLE, THE FORM FOR INDIVIDUAL ACCREDITED INVESTORS
ATTACHED AS EXHIBIT D.

 

IN WITNESS WHEREOF, CohBar, Inc. hereby accepts
the above subscription, as of the date set forth below:

 

COHBAR, INC.

 

	By:	 	 
	Name:	 	 
	Title:	 	 
	
        Date:
	 	 

    	 	8	 

     

    

 

EXHIBIT A

 

FORM OF WARRANT

 

[See Attached]

 

    	 	9	 

     

    

 

EXHIBIT B

 

INVESTOR QUESTIONNAIRE

 

The information
contained herein is being furnished to CohBar, Inc., a Delaware corporation (the “Company”), in order for the Company
to determine whether the undersigned’s subscription for Units of the Company may be accepted pursuant to Section 4(2) of
the Securities Act of 1933, as amended (the “1933 Act”) and/or Rule 506 of Regulation D promulgated thereunder (“Regulation
D”). The Units are being offered without registration under the 1933 Act or the securities laws of any state or any other
jurisdiction. Under the 1933 Act and/or certain state securities laws, the Company may be required to determine that an individual,
an investing entity and/or each individual equity owner of an investing entity meets certain suitability requirements before selling
the Units to such individual or entity.

 

The undersigned
Investor understands that: (i) the Company will rely upon the following information; (ii) the Units and the Common Stock issuable
upon conversion and exercise of the Warrants included in the Units, will not be registered under the 1933 Act in reliance upon
the exemptions from registration provided by Section 4(2) of the 1933 Act and/or Rule 506 of Regulation D (although the Company
has agreed to use its commercially reasonable efforts to register the resale of the Common Stock included in the Units and issuable
upon exercise of the Warrants included in the Units); (iii) this Confidential Investor Questionnaire is not an offer to sell or
a solicitation of any offer to buy or sell the Units or any other securities to the undersigned; and (iv) no subscription for any
Units will be accepted unless the Subscriber is an Accredited Investor.

 

Your answers
will be kept strictly confidential. However, by signing this Questionnaire, you agree that the Company may present this Questionnaire
to such parties as it deems appropriate if called upon to establish the Company’s entitlement to an exemption under the 1933
Act or any applicable state securities laws.

 

PLEASE ANSWER ALL QUESTIONS

 

If the appropriate answer is “None” or
“Not Applicable”, so state. Attach additional sheets if necessary to complete your answers to any item. The undersigned
makes the following representations and warranties:

 

		1.	Name: 	 

 

Name of spouse or additional purchaser: ________________________________________________________________

 

If an Entity, type of Entity (e.g. Corporation, LLC,
Partnership, Trust, etc.) and State of Organization:

 

____________________________________________              State: _____________________________

 

Date of Birth or Date of Trust: ______________________________________________________________________

 

		2.	Home address or, if other than an individual, principal
office address: __________________________

 

_____________________________________________________________________________________________

 

Telephone number: ______________________________________________________________________________

 

Social Security Number: ___________________________________________________________________________

 

Tax Identification Number: _________________________________________________________________________

 

		3.	The undersigned is an accredited investor (as defined
in Rule 501(a) of Regulation D) because the undersigned is (check each appropriate description):

 

                  ____________              If
you are an individual (not an entity), your individual net worth, or joint net worth with your spouse or spousal equivalent,
exceeds $1,000,000, excluding the value of your primary residence.

 

    	 	10	 

     

    

 

                  ____________              If
you are an individual (not an entity), you personally have had an individual income in excess of $200,000 in each of the two
(2) most recent calendar years and you reasonably expect an income in excess of $200,000 in the current calendar year.

 

                  ____________              If
you are an individual (not an entity), your joint income with your spouse or spousal equivalent is in excess of $300,000 in
each of the two (2) most recent calendar years and you reasonably expect a joint income in excess of $300,000 in the current calendar
year.

 

                  ____________              If
you are an individual (not an entity), you hold at least one of the following licenses in good standing: a Series 7, Series
65 or Series 82 license.

 

                  ____________              If
you are an individual (not an entity), you are a family client whose investments are directed by a qualifying family office
(defined below).

 

                  ____________              If
you are an entity, you have total assets in excess of $5,000,000, have not been formed for the purpose of investing in the
Company, and are one of the following: (1) an organization described in Section 501(c)(3) of the Internal Revenue Code of 1986,
(2) a corporation, (3) a Massachusetts or similar business trust, (4) a partnership, or (5) a limited liability company.

 

                  ____________              If
you are a trust (other than a business trust), with total assets in excess of $5,000,000 which was not formed for the purpose
of investing in the Company and whose decision to invest has been directed by a person who has such knowledge and experience in
financial and business matters that such person is capable of evaluating the merits and risks of investment.

 

                  ____________             If you are an entity (e.g., corporation,
partnership, limited liability company, or trust), you are registered as an investment adviser under either the Investment Advisers
Act of 1940 or pursuant to the laws of any state of the United States

 

                  ____________             If you are an entity (e.g., corporation,
partnership, limited liability company, or trust), you are an investment adviser relying on the exemption from registering with
the Securities and Exchange Commission under Section 203(l) or (m) of the Investment Advisers Act of 1940.

 

                  ____________             If you are an entity (e.g., corporation,
partnership, limited liability company, or trust), you are a Rural Business Investment Company.

 

                  ____________             If you are an entity (e.g., corporation,
partnership, limited liability company, or trust), you are a family office as defined in Rule 202(a)(11)(G)–1 under the
Advisers Act and you were not formed for the specific purpose of acquiring the securities offered, you own investments in excess
of $5 million, and your investment is directed by a person with such knowledge and experience in financial and business matters
that such family office is capable of evaluating the merits and risks of the prospective investment (a “qualifying
family office”).

 

                  ____________             If you are an entity (e.g., corporation,
partnership, limited liability company, or trust), you are a family client whose investments are directed by a qualifying family
office.

 

                  ____________             If you are an entity not otherwise referred
to in any of the boxes above, you were not formed for the specific purpose of acquiring the securities offered and you own investments
in excess of $5 million.

 

                  ____________             If you are an entity (e.g., corporation,
partnership, limited liability company, or trust), each of your equity owners satisfies one or more of the above criteria. In
reviewing equity ownership, it is permissible to look through various forms of equity ownership to natural persons; if those natural
persons are themselves accredited investors, and if all other equity owners of the entity seeking accredited investor status are
accredited investors, then this box may be checked.

 

    	 	11	 

     

    

 

		4.	The undersigned, if a resident of Canada, is one or more
of the following:

 

(complete only if resident of Canada, check each
appropriate description):

 

	 	__________	(a) purchasing the Units as principal and is an “Accredited Investor” within the meaning of National Instrument 45-106 entitled “Prospectus Exemptions” (“NI 45-106”);
	 	 	 
	 	 	(Important Note: You must also complete the Canadian Accredited Investor Certificate attached as Exhibit C and, if applicable, the Canadian Individual Accredited Investor Form at Exhibit D.)
	 	 	 
	 	__________	(b) a non-individual purchasing as principal such number of Units having an acquisition cost to the Investor of not less than Cdn$150,000 paid in cash at the time of Closing; or
	 	 	 
	 	__________	(c) purchasing the Units as principal and is (check the appropriate box below)

 

	 	☐	(i)	a director, executive officer or control person of the Company (as such terms are defined in NI 45-106) or of an affiliate of the Company; or
	 	☐	(ii)	a spouse (as such term is defined in NI 45-106), parent, grandparent, brother, sister, child or grandchild of [insert name], a person referred to in (i) above; or
	 	☐	(iii)	a parent, grandparent, brother, sister, child or grandchild of [insert name], the spouse of a person referred to in (i) above; or
	 	☐	(iv)	a close personal friend of [insert name], a person referred to in (i) above; or
	 	☐	(v)	a close business associate of [insert name], a person referred to in (i) above; or
	 	☐	(vi)	a founder of the Company or a spouse, parent, grandparent, brother, sister, child, grandchild, close personal friend or close business associate of a founder of the Company; or
	 	☐	(vii)	a parent, grandparent, brother, sister, child or grandchild of [insert name], the spouse of a founder of the Company; or
	 	☐	(viii)	a person of which a majority of the voting securities are beneficially owned by, or a majority of the directors are, persons described in (i) to (vii) above; or
	 	☐	(ix)	a trust or estate of which all the beneficiaries or a majority of the trustees or executors are persons described in (i) to (vii) above.

 

		5.	If the undersigned, is a resident of Canada, check the
following, if applicable (complete only if resident of Canada):

 

	 	__________	the undersigned is a registrant pursuant to
    applicable Canadian securities laws; and/or
	 	 	 
	 	__________	the undersigned is an insider of the Company
    pursuant to applicable Canadian securities laws.

 

    	 	12	 

     

    

 

SIGNATURE PAGE TO INVESTOR
QUESTIONNAIRE

 

The undersigned
represents and warrants to the Company that foregoing responses are complete and accurate. The undersigned will provide such further
information as may be requested by the Company to verify the foregoing. The undersigned will notify the Company in writing regarding
any material change in its responses prior to the Closing of the purchase of Units by the undersigned. Absent such notification,
the issuance of the Units shall be deemed to be an automatic affirmation by the undersigned of the truth and accuracy or the statements
and information set forth above.

 

Date: ______________

 

	 	 
	 	(Exact
    name of Investor)
	 	 	 
	 	By:	         
	 	(Signature)
	 	 	 
	 	 
	 	(Name
    of above signatory)
	 	 
	 	(Title,
    if applicable)
	 	 
	 	(Additional
    Signature, if applicable, e.g., joint tenants)
	 	 
	 	(Name
    of Additional Signatory) 

 

    	 	13	 

     

    

 

EXHIBIT C

 

CANADIAN ACCREDITED INVESTOR
CERTIFICATE

 

TO BE COMPLETED ONLY IF
THE INVESTOR IS RESIDENT IN CANADA

 

TO: CohBar, Inc. (the “Company”)

 

In connection with the issuance
by the Company of common stock and warrants to the undersigned, the undersigned hereby represents, warrants and certifies to the
Company that:

 

		1.	the undersigned is an “Accredited Investor”
as defined in NI 45-106 or section 73.3 of the Securities Act (Ontario), on the basis that the undersigned fits within
the category of Accredited Investor which the undersigned has indicated below; and

 

		2.	the undersigned was not created and is not being used
solely to purchase or hold securities as an Accredited Investor described in paragraph (m) below.

 

The undersigned has indicated
below the categories which the undersigned satisfies in order to qualify as an “Accredited Investor” [Please initial
or place a checkmark above the line to the left of each applicable item, complete the relevant information, if applicable, and
sign this certificate].

 

	_______	(a)	a Schedule I, II or III bank, or a Canadian financial
institution

 

	_______	(b)	the Business Development Bank of Canada

 

	_______	(c)	a subsidiary of any person referred to in paragraph (a) or (b), if the person owns all of the voting securities of the subsidiary,
except the voting securities required by law to be owned by directors of that subsidiary

 

	_______	(d)	a person registered under the securities legislation
of a jurisdiction of Canada as an adviser or dealer

 

	_______	(e)	an individual registered under the securities legislation of a jurisdiction of Canada as a representative of a person referred
to in paragraph (d)

 

	_______	(e.1)	an individual formerly registered under the securities
legislation of a jurisdiction of Canada, other than an individual formerly registered solely as a representative of a limited
market dealer under one or both of the Securities Act (Ontario) or the Securities Act (Newfoundland and Labrador)

 

	_______	(f)	the Government of Canada or a jurisdiction of Canada, or any crown corporation, agency or wholly owned entity of the Government
of Canada or a jurisdiction of Canada

 

	_______	(g)	a municipality, public board or commission in Canada
and a metropolitan community, school board, the Comité de gestion de la taxe scolaire de l’île de Montréal
or an intermunicipal management board in Québec

 

	_______	(h)	any national, federal, state, provincial, territorial or municipal government of or in any foreign jurisdiction, or any agency
of that government

 

	_______	(i)	a pension fund that is regulated by either the Office of the Superintendent of Financial Institutions (Canada) or a pension
commission or similar regulatory authority of a jurisdiction of Canada

 

{Note: If you are an accredited investor described
in paragraphs (j), (k) or (l) below you must also deliver a completed Form 45-106F9 –Form for Individual Accredited Investors
(Exhibit D).}

 

    	 	14	 

     

    

 

	_______	(j)	an individual who, either alone or with a spouse, beneficially owns financial assets having an aggregate realizable value that,
before taxes but net of any related liabilities, exceeds Cdn$1,000,000

 

{Note: Financial assets include
cash and securities, but do not include a personal residence – see the definition of “financial assets” later
in this certificate. Financial assets are generally liquid or relatively easy to liquidate. You must subtract any liabilities related
to your financial assets to calculate your net financial assets—see the definition of “related liabilities”.
Financial assets held in a group RRSP under which you do not have the ability to acquire the financial assets and deal with them
directly are not considered to be beneficially owned by you.

 

	_______	(j.1)	an individual who beneficially owns financial assets
having an aggregate realizable value that, before taxes but net of any related liabilities, exceeds Cdn$5,000,000

 

{Note: The financial assets of your spouse (including
financial assets in a spousal RRSP) cannot be included in the calculation of net financial assets under this paragraph (j.1).}

 

	_______	(k)	an individual whose net income before taxes exceeded
Cdn$200,000 in each of the two most recent calendar years or whose net income before taxes combined with that of a spouse exceeded
Cdn$300,000 in each of the two most recent calendar years and who, in either case, reasonably expects to exceed that net income
level in the current calendar year

 

	_______	(l)	an individual who, either alone or with a spouse, has
net assets of at least Cdn$5,000,000

 

{Note: To calculate net assets,
take the value of your total assets (which may include a personal residence) and subtract your total liabilities (which may include
a mortgage). The value attributed to assets should reasonably reflect their estimated fair value. Income tax should be considered
a liability if the obligation to pay it is outstanding at the time of the subscription.}

 

	_______	(m)	a person, other than an individual or investment fund,
that has net assets of at least Cdn$5,000,000 as shown on its most recently prepared financial statements

 

	_______	(n)	an investment fund that distributes or has distributed
its securities only to:

 

		(i)	a person that is or was an accredited investor at the
time of the distribution;

 

		(ii)	a person that acquires or acquired securities in the
circumstances referred to in sections 2.10 (Minimum amount investment), or 2.19 (Additional investment in investment
funds) of NI 45-106; or

 

		(iii)	a person described in paragraph (i) or (ii) that acquires
or acquired securities under section 2.18 (Investment fund reinvestment) of NI 45-106

 

	_______	(o)	an investment fund that distributes or has distributed
securities under a prospectus in a jurisdiction of Canada for which the regulator or, in Québec, the securities regulatory
authority, has issued a receipt

 

	_______	(p)	a trust company or trust corporation registered or authorized
to carry on business under the Trust and Loan Companies Act (Canada) or under comparable legislation in a jurisdiction
of Canada or a foreign jurisdiction, acting on behalf of a fully managed account managed by the trust company or trust corporation,
as the case may be

 

	_______	(q)	a person acting on behalf of a fully managed account
managed by that person, if that person is registered or authorized to carry on business as an adviser or the equivalent under
the securities legislation of a jurisdiction of Canada or a foreign jurisdiction

 

    	 	15	 

     

    

 

	_______	(r)	a registered charity under the Income Tax Act (Canada)
that, in regard to the trade, has obtained advice from an eligibility adviser or an adviser registered under the securities legislation
of the jurisdiction of the registered charity to give advice on the securities being traded

 

	_______	(s)	an entity organized in a foreign jurisdiction that is
analogous to any of the entities referred to in paragraphs (a) to (d) or paragraph (i) in form and function

 

	_______	(t)	a person in respect of which all of the owners of interests,
direct, indirect or beneficial, except the voting securities required by law to be owned by directors, are persons that are accredited
investors

 

{Note: If you have initialed
this paragraph (t), name each owner of an interest, and indicate the category of accredited investor into which that person fits
(by reference to the paragraph numbers in this Exhibit C). If a person named below is a director required by law to own
a voting security, and that person is not an accredited investor, indicate “director” under Category.}

 

Name:
____________________     Category: ____________________

 

	_______	(u)	a trust established by an accredited investor for the
benefit of the accredited investor’s family members of which a majority of the trustees are accredited investors and all
of the beneficiaries are the accredited investor’s spouse, a former spouse of the accredited investor or a parent, grandparent,
brother, sister, child or grandchild of that accredited investor, of that accredited investor’s spouse or of that accredited
investor’s former spouse

 

{Note: If you have initialed
this paragraph (u), name the person who established the trust and each trustee, and indicate the category of accredited investor
into which that person fits (by reference to the paragraph numbers in this Exhibit C). If a person named below is not an
accredited investor, indicate “N/A” under Category.}

 

Person who established trust: ___________
Category: _____________

 

Trustee(s): _______________________________________________

 

	_______	(v)	an investment fund that is advised by a person registered as an adviser or a person that is exempt from registration as an
adviser

 

	_______	(w)	a person that is recognized or designated by the securities regulatory authority or, except in Ontario and Québec, the
regulator as an accredited investor

 

[Signature Page Follows]

 

    	 	16	 

     

    

 

SIGNATURE PAGE TO CANADIAN
ACCREDITED INVESTOR CERTIFICATE

 

The undersigned
represents and warrants to the Company that foregoing responses are complete and accurate. The undersigned will provide such further
information as may be requested by the Company to verify the foregoing. The undersigned will notify the Company in writing regarding
any material change in its responses prior to the Closing of the purchase of Units by the undersigned. Absent such notification,
the issuance of the Units shall be deemed to be an automatic affirmation by the undersigned of the truth and accuracy or the statements
and information set forth above.

 

Date: ___________________

 

	 	 
	 	(Exact name of Investor)
	 	 	 
	 	By:	                              
	 	(Signature)
	 	 
	 	(Name of above signatory)
	 	 
	 	 
	 	(Title, if applicable)
	 	 
	 	 
	 	(Additional Signature, if applicable,
    e.g., joint tenants)
	 	 
	 	 
	 	(Name of Additional Signatory)

 

    	 	17	 

     

    

 

Appendix to Canadian Accredited
Investor Certificate – Definitions

 

As used in this certificate, the following terms have
the following meanings.

 

“Canadian financial institution” means:

 

		(a)	an association governed by the Cooperative Credit Associations
Act (Canada) or a central cooperative credit society for which an order has been made under section 473(1) of that Act; and

 

		(b)	in Ontario, also means a loan corporation, trust company,
trust corporation, insurance company, treasury branch, credit union, caisse populaire, financial services cooperative or
credit union league or federation that is authorized by a statute of Canada or Ontario to carry on business in Canada or Ontario,
as the case may be; and

 

		(c)	outside of Ontario, also means a loan corporation, trust
company, trust corporation, insurance company, treasury branch, credit union, caisse populaire, financial services cooperative,
or league that, in each case, is authorized by an enactment of Canada or a jurisdiction of Canada to carry on business in Canada
or a jurisdiction of Canada.

 

“eligibility adviser” means:

 

		(a)	a person that is registered as an investment dealer and
authorized to give advice with respect to the type of security being distributed; and

 

		(b)	in Manitoba, also means a lawyer who is a practicing member
in good standing with a law society of a jurisdiction of Canada or a public accountant who is a member in good standing of an
institute or association of chartered accountants, certified general accountants or certified management accountants in a jurisdiction
of Canada provided that the lawyer or public accountant must not:

 

		(i)	have a professional, business or personal relationship
with the issuer, or any of its directors, executive officers, founders or control persons; and

 

		(ii)	have acted for or been retained personally or otherwise
as an employee, executive officer, director, associate or partner of a person that has acted for or been retained by the issuer
or any of its directors, executive officers, founders or control persons within the previous 12 months.

 

“executive officer” means, for an
issuer, an individual who is:

 

		(a)	a chair, vice-chair or president;

 

		(b)	a vice-president in charge of a principal business unit,
division or function including sales, finance or production; or

 

		(c)	performing a policy-making function in respect
of the issuer.

 

“financial assets” means:

 

		(a)	cash;

 

		(b)	securities; or

 

		(c)	a contract of insurance, a deposit or an evidence of a
deposit that is not a security for the purposes of securities legislation.

 

“foreign jurisdiction” means a country
other than Canada or a political subdivision of a country other than Canada.

 

    	 	18	 

     

    

 

“founder” means, in respect of an
issuer, a person who:

 

		(a)	acting alone, in conjunction, or in concert with one or
more persons, directly or indirectly, takes the initiative in founding, organizing or substantially reorganizing the business
of the issuer; and

 

		(b)	at the time of the distribution or trade is actively involved
in the business of the issuer.

 

“investment fund” has the same meaning
as in National Instrument 81-106 — Investment Fund Continuous Disclosure and means a mutual fund or a non-redeemable investment
fund.

 

“jurisdiction of Canada” means a
province or territory of Canada.

 

“non-redeemable investment fund” means an issuer:

 

		(a)	whose primary purpose is to invest money provided by its
securityholders;

 

		(b)	that does not invest:

 

		(i)	for the purpose of exercising or seeking to exercise
control of an issuer, other than an issuer that is a mutual fund or a non-redeemable investment fund; or

 

		(ii)	for the purpose of being actively involved in the
management of any issuer in which it invests, other than an issuer that is a mutual fund or a non-redeemable investment fund;
and

 

		(c)	that is not a mutual fund.

 

“person”
includes:

 

		(a)	an individual;

 

		(b)	a corporation;

 

		(c)	a partnership, trust, fund and an association, syndicate,
organization or other organized group of persons, whether incorporated or not; and

 

		(d)	an individual or other person in that person’s capacity
as a trustee, executor, administrator or personal or other legal representative.

 

“related liabilities” means:

 

		(a)	liabilities incurred or assumed for the purpose of financing
the acquisition or ownership of financial assets; or

 

		(b)	liabilities
that are secured by financial assets.

 

“spouse”
means an individual who:

 

		(a)	is
married to another individual and is not living separate and apart within the meaning of the Divorce Act (Canada), from the other
individual;

 

		(b)	is living with another individual in a marriage-like relationship,
including a marriage-like relationship between individuals of the same gender; or

 

		(c)	in Alberta, is an individual referred to in paragraph (a)
or (b), or is an adult interdependent partner within the meaning of the Adult Interdependent Relationships Act (Alberta).

 

“subsidiary” means an issuer that
is controlled directly or indirectly by another issuer and includes a subsidiary of that subsidiary.

 

    	 	19	 

     

    

 

EXHIBIT D

 

FORM 45-106F9

 

FORM FOR INDIVIDUAL CANADIAN
ACCREDITED INVESTORS

 

THIS EXHIBIT D MUST BE COMPLETED IF THE INVESTOR
IS AN INDIVIDUAL RESIDENT OF CANADA DESCRIBED IN CATEGORY (j), (k) OR (l) OF THE CANADIAN ACCREDITED INVESTOR CERTIFICATE.

 

	
        WARNING!

         

        This investment is risky.
        Don’t invest unless you can afford to lose all the money you pay for this investment.

	SECTION 1 TO BE COMPLETED BY THE ISSUER OR SELLING SECURITY HOLDER
	1. About your investment
	Type of securities: Units	Issuer: CohBar, Inc.
	Purchased from: CohBar, Inc.
	SECTIONS 2 TO 4 TO BE COMPLETED BY THE PURCHASER
	2. Risk acknowledgement
	
         

        This investment is risky. Initial that you understand
        that:
	Your initials
	Risk  of loss – You could lose your entire investment of $ ____________. (Instruction: Insert the total dollar amount of the investment.)	 
	Liquidity risk – You may not be able to sell your investment quickly – or at all.	 
	Lack of Information – You may receive little or no information about your investment.	 
	Lack of advice – You will not receive advice from the salesperson about whether this investment is suitable for you unless the salesperson is registered. The salesperson is the person who meets with, or provides information to, you about making this investment. To check whether the salesperson is registered, go to www.aretheyregistered.ca.	 
	3. Accredited investor status
	
        You must meet at least one of the
        following criteria to be able to make this investment. Initial the statement that applies to you. (You may initial more than
        one statement.) The person identified in section 6 is responsible for ensuring that you meet the definition of accredited
        investor. That person, or the salesperson identified in section 5, can help you if you have questions about whether you meet
        these criteria.
	
         

        Your initials

	
        ●  Your
        net income before taxes was more than Cdn$200,000 in each of the 2 most recent calendar years, and you expect it to be more
        than Cdn$200,000 in the current calendar year. (You can find your net income before taxes on your personal income tax
        return.)
	 
	
        ●  Your
        net income before taxes combined with your spouse’s was more than Cdn$300,000 in each of the 2 most recent calendar
        years, and you expect your combined net income before taxes to be more than Cdn$300,000 in the current calendar year.
	 
	●  Either alone or with your spouse, you own more than Cdn$1 million in cash and securities, after subtracting any debt related to the cash and securities.	 
	●  Either alone or with your spouse, you have net assets worth more than Cdn$5 million. (Your net assets are your total assets (including real estate) minus your total debt.)	 
	4. Your name and signature
	By signing this form, you confirm that you have read this form and you understand the risks of making this investment as identified in this form.
	First and last name (please print):
	Signature:	Date:
		 	 

	SECTION 5 TO BE COMPLETED BY THE SALESPERSON
	5. Salesperson information
	(Instruction: The salesperson is the person who meets with, or provides information to, the purchaser with respect to making this investment. That could include a representative of the issuer or selling security holder, a registrant or a person who is exempt from the registration requirement.)
	First and last name of salesperson (please print):
	Telephone:	Email:
	Name of firm (if registered):
	SECTION 6 TO BE COMPLETED BY THE ISSUER OR SELLING SECURITY HOLDER
	6. For more information about this investment
	
         

        CohBar, Inc.

        Attn: Jeffrey Biunno, Chief Financial Officer

        277
        Fairfield Road, STE. 332

        Fairfield, NJ 07004

        Phone: (650) 446-7888, option 3

         

        For more information about prospectus exemptions,
        contact your local securities regulator. You can find contact information at www.securities-administrators.ca.

 

(The Investor should keep one copy of this form
(signed by the Investor) for the Investor’s records.)

 

    	 	20	 

     

    

 

EXHIBIT
E

CONTACT INFORMATION

 

	
        Alberta Securities Commission

        Suite 600, 250–5th
        Street SW

        Calgary, Alberta T2P 0R4

        Telephone: (403) 297-6454

        Toll free in Canada: 1-877-355-0585

        Facsimile: (403)
        297-2082
	
        British Columbia Securities Commission

        P.O. Box 10142, Pacific Centre

        701 West Georgia Street

        Vancouver, British Columbia V7Y 1L2

        Inquiries: (604)
        899-6854

        Toll free in Canada: 1-800-373-6393

        Facsimile: (604)
        899-6581

        Email: inquiries@bcsc.bc.ca

	 	 
	
        The Manitoba Securities Commission

        500-400 St. Mary Avenue

        Winnipeg, Manitoba R3C 4K5

        Telephone: (204) 945-2548

        Toll free in Manitoba: 1-800-655-5244

        Facsimile: (204)
        945-0330
	
        Financial and Consumer Services

        Commission (New
        Brunswick)

        85 Charlotte Street, Suite 300

        Saint John, New Brunswick E2L 2J2

        Telephone: (506)
        658-3060

        Toll free in Canada: 1-866-933-2222

        Facsimile: (506)
        658-3059

        Email: info@fcnb.ca

	 	 
	
        Government of Newfoundland and Labrador

        Financial
        Services Regulation Division

        P.O. Box 8700

        Confederation Building

        2nd
        Floor, West Block

        Prince Philip Drive

        St. John’s, Newfoundland and Labrador A1B 4J6

        Attention:

        Director of Securities

        Telephone: (709) 729-4189

        Facsimile: (709) 729-6187
	
        Government of the Northwest Territories

        Office
        of the Superintendent of Securities

        P.O. Box 1320

        Yellowknife, Northwest Territories X1A 2L9

        Attention:
        Deputy Superintendent, Legal & Enforcement

        Telephone: (867) 920-8984

        Facsimile: (867) 873-0243

	 	 
	
        Nova Scotia Securities Commission

        Suite 400, 5251 Duke Street 

Duke Tower

        P.O. Box 458

        Halifax, Nova Scotia B3J 2P8

        Telephone: (902) 424-7768

        Facsimile: (902) 424-4625
	
        Government of Nunavut

        Department of Justice 

        Legal
        Registries Division

        P.O. Box 1000, Station 570

        1st Floor,
        Brown Building

        Iqaluit, Nunavut X0A 0H0

        Telephone: (867) 975-6590

        Facsimile: (867) 975-6594

	 	 
	
        Ontario Securities Commission

        20 Queen Street
        West, 22nd Floor

        Toronto, Ontario M5H 3S8

        Telephone: (416) 593-8314

        Toll free in Canada: 1-877-785-1555

        Facsimile: (416)
        593-8122

        Email: exemptmarketfilings@osc.gov.on.ca

        Public official contact regarding indirect collection
        of information: Inquiries Officer
	
        Prince Edward Island Securities Office

        95 Rochford Street, 4th Floor Shaw Building

        P.O. Box 2000

        Charlottetown, Prince Edward Island C1A 7N8

        Telephone:
        (902) 368-4569

        Facsimile: (902) 368-5283

	 	 

	
        Autorité des marchés financiers

        800, Square Victoria, 22e étage

        C.P. 246, Tour de la Bourse

        Montréal, Québec
        H4Z 1G3

        Telephone: (514) 395-0337 or 1-877-525-0337

        Facsimile: (514) 864-6381 (For privacy requests only)

        Email: financementdessocietes@lautorite.qc.ca

        (For
        corporate finance issuers);

        fonds_dinvestissement@lautorite.qc.ca (for investment
        fund issuers)
	
        Financial and Consumer Affairs 

        Authority of Saskatchewan

        Suite 601–1919 Saskatchewan Drive

        Regina, Saskatchewan
        S4P 4H2

        Telephone: (306) 787-5879

        Facsimile: (306) 787-5899

	 	 
	
        Government of Yukon

        Department of Community Services

        Law Centre, 3rd Floor

        2130 Second Avenue

        Whitehorse, Yukon Y1A 5H6

        Telephone: (867) 667-5314

        Facsimile: (867) 393-6251
	 

 

    	 	21	 

     

    

 

EXHIBIT E

 

NOTE TERMINATION AGREEMENT

 

[See Attached]

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

22

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00318-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00318-of-00352.parquet"}]]